| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | soluble NSF attachment protein activity | 1.23e-06 | 3 | 215 | 3 | GO:0005483 | |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 1.10e-06 | 3 | 214 | 3 | GO:0071691 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | GDF5 NCOA3 ZNF609 ZBTB16 TRPC5 CEACAM7 PLXNB2 ITGB3 SLITRK1 STAT5A STAT5B MET PARP1 NDEL1 PTPRD FGF8 MME GOLGA2 AKIRIN1 APOB ECT2 ZNF365 SH3PXD2B SMARCA4 ROBO1 CAPRIN1 XRCC6 PCID2 SOD2 | 7.49e-06 | 1141 | 214 | 29 | GO:0045597 |
| GeneOntologyBiologicalProcess | liver development | CEACAM7 HMGCS2 STAT5B MET NPC1 RPGRIP1L LIPA NPHP3 CSNK2A2 SMARCA4 SOD2 | 8.93e-06 | 202 | 214 | 11 | GO:0001889 |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | CEACAM7 HMGCS2 STAT5B MET NPC1 RPGRIP1L LIPA NPHP3 CSNK2A2 SMARCA4 SOD2 | 1.03e-05 | 205 | 214 | 11 | GO:0061008 |
| GeneOntologyBiologicalProcess | positive regulation of cell development | ZNF609 ZBTB16 TRPC5 PLXNB2 ITGB3 SLITRK1 STAT5A STAT5B MET NDEL1 PTPRD MME GOLGA2 ZNF365 SMARCA4 ROBO1 CAPRIN1 XRCC6 PCID2 | 2.35e-05 | 614 | 214 | 19 | GO:0010720 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH11 SPTBN1 NEB ITGB3 MET ARHGEF7 PIK3R2 MYO3B DLG1 PLEC PREX1 SELE FLNB CACNA2D1 NRAP NEBL ARHGEF5 ECT2 OPHN1 SH3PXD2B CELSR1 XIRP2 MYO15A PDCD10 | 2.81e-05 | 912 | 214 | 24 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH11 SPTBN1 NEB ITGB3 MET ARHGEF7 PIK3R2 MYO3B DLG1 PLEC PREX1 FLNB NRAP NEBL ARHGEF5 ECT2 OPHN1 SH3PXD2B CELSR1 XIRP2 MYO15A PDCD10 | 3.40e-05 | 803 | 214 | 22 | GO:0030036 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | MYH11 NEB MET PIK3R2 PLEC NRAP NEBL ARHGEF5 ECT2 SH3PXD2B PDCD10 | 4.25e-05 | 239 | 214 | 11 | GO:0031032 |
| GeneOntologyBiologicalProcess | cell morphogenesis | SART3 TRPC5 TTC3 PLXNB2 ITGB3 SLITRK1 MET NDEL1 PTPRD ARHGEF7 MYO3B VPS13A DLG1 FGF8 KEL FLRT1 PLEC GOLGA2 CNP FLNB ECT2 ZNF365 OPHN1 TMEM106B LIPA SMARCA4 ROBO1 CAPRIN1 | 4.63e-05 | 1194 | 214 | 28 | GO:0000902 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | CENPC CENPE SPTBN1 TUBGCP4 DCTN1 STAT5A STAT5B MET NDEL1 DLG1 FGF8 GOLGA2 CUL1 POLA1 PARP3 SMC4 SMC2 ECT2 ZNF365 HINFP LIPA MEIOC SMARCA4 ANKFN1 PCID2 | 5.51e-05 | 1014 | 214 | 25 | GO:0000278 |
| GeneOntologyBiologicalProcess | kinetochore organization | 5.87e-05 | 21 | 214 | 4 | GO:0051383 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MYH11 SPTBN1 TUBGCP4 NEB DCTN1 MET NDEL1 ARHGEF7 PIK3R2 KRT77 PKP1 DLG1 PLEC PREX1 GOLGA2 KRT78 NRAP NEBL ARHGEF5 SH3PXD2B XIRP2 LUM MYO15A PDCD10 | 6.02e-05 | 957 | 214 | 24 | GO:0097435 |
| GeneOntologyBiologicalProcess | cell cycle process | CENPC CENPE SPTBN1 TUBGCP4 WDR76 DCTN1 MET KLHL9 NDEL1 SEPTIN14 DLG1 FGF8 PLEC GOLGA2 DEUP1 CUL1 POLA1 PARP3 WRN SMC4 CENPU TEX15 SMC2 ECT2 ZNF365 HINFP MEIOC CSNK2A2 SMARCA4 ANKFN1 PCID2 | 8.83e-05 | 1441 | 214 | 31 | GO:0022402 |
| GeneOntologyBiologicalProcess | cilium movement | CATSPERD TTC21A GAS8 MET VPS13A DNAH6 APOB NPHP3 DNAI2 CCDC63 DNAH11 | 9.37e-05 | 261 | 214 | 11 | GO:0003341 |
| GeneOntologyBiologicalProcess | development of secondary female sexual characteristics | 1.25e-04 | 10 | 214 | 3 | GO:0046543 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway via JAK-STAT | 1.25e-04 | 10 | 214 | 3 | GO:0060397 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | CENPE SPTBN1 NEB DCTN1 ITGB3 MET PARP1 PTPRD ARHGEF7 PIK3R2 MYO3B DLG1 FGF8 PREX1 USP36 ARHGEF5 PARP3 SMC4 SMC2 ECT2 TMEM106B SH3PXD2B CELSR1 XIRP2 CSNK2A2 SMARCA4 PDCD10 CAPRIN1 PCID2 | 1.41e-04 | 1342 | 214 | 29 | GO:0033043 |
| GeneOntologyBiologicalProcess | hindlimb morphogenesis | 1.51e-04 | 49 | 214 | 5 | GO:0035137 | |
| GeneOntologyBiologicalProcess | double-strand break repair | PARP1 RAD52 POLA1 PARP3 WRN TEX15 HELQ ZNF365 MEIOC CSNK2A2 SMARCA4 XRCC6 | 1.53e-04 | 324 | 214 | 12 | GO:0006302 |
| GeneOntologyBiologicalProcess | response to interleukin-2 | 1.71e-04 | 11 | 214 | 3 | GO:0070669 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | SPTBN1 NEB ITGB3 MET PIK3R2 MYO3B DLG1 PREX1 ARHGEF5 ECT2 SH3PXD2B CELSR1 XIRP2 | 1.99e-04 | 384 | 214 | 13 | GO:0032956 |
| GeneOntologyBiologicalProcess | microtubule-based movement | CATSPERD CENPE TTC21A GAS8 DCTN1 MET NDEL1 VPS13A DNAH6 APOB LRPPRC NPHP3 DNAI2 CCDC63 DNAH11 | 2.08e-04 | 493 | 214 | 15 | GO:0007018 |
| GeneOntologyBiologicalProcess | response to interleukin-15 | 2.26e-04 | 12 | 214 | 3 | GO:0070672 | |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 2.87e-04 | 122 | 214 | 7 | GO:0045132 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | GDF5 NCOA3 CACNA2D2 SLITRK1 STAT5A STAT5B VPS13A DLG1 PLEC SH3PXD2B | 2.87e-04 | 249 | 214 | 10 | GO:0035264 |
| GeneOntologyBiologicalProcess | development of secondary sexual characteristics | 2.92e-04 | 13 | 214 | 3 | GO:0045136 | |
| GeneOntologyBiologicalProcess | microtubule nucleation | 3.10e-04 | 57 | 214 | 5 | GO:0007020 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 3.19e-04 | 3 | 214 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | DNA ADP-ribosylation | 3.19e-04 | 3 | 214 | 2 | GO:0030592 | |
| GeneOntologyBiologicalProcess | SNARE complex disassembly | 3.19e-04 | 3 | 214 | 2 | GO:0035494 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | TRPC5 PLXNB2 SLITRK1 MET NDEL1 PTPRD MME GOLGA2 ZNF365 ROBO1 CAPRIN1 XRCC6 | 3.45e-04 | 354 | 214 | 12 | GO:0050769 |
| GeneOntologyBiologicalProcess | heart development | MYH11 NEB TRIP11 NDUFV2 MET FGF8 PLEC RPGRIP1L NRAP NEBL PCDHA10 THBS1 SH3PXD2B NPHP3 XIRP2 SMARCA4 ROBO1 SOD2 DNAH11 | 3.60e-04 | 757 | 214 | 19 | GO:0007507 |
| GeneOntologyBiologicalProcess | chromosome segregation | CENPC CENPE TUBGCP4 NDEL1 GOLGA2 SMC4 CENPU TEX15 SMC2 ECT2 MEIOC CSNK2A2 SMARCA4 PCID2 | 3.76e-04 | 465 | 214 | 14 | GO:0007059 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | SPTBN1 NEB DCTN1 ITGB3 MET ARHGEF7 PIK3R2 MYO3B DLG1 PREX1 ARHGEF5 PARP3 ECT2 SH3PXD2B CELSR1 XIRP2 | 3.76e-04 | 579 | 214 | 16 | GO:0051493 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TRPC5 TTC3 PLXNB2 ITGB3 SLITRK1 MET NDEL1 PTPRD ARHGEF7 VPS13A FGF8 KEL FLRT1 GOLGA2 CNP ZNF365 OPHN1 TMEM106B ROBO1 CAPRIN1 | 3.99e-04 | 826 | 214 | 20 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of multicellular organism growth | 4.19e-04 | 93 | 214 | 6 | GO:0040014 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | TRPC5 PLXNB2 SLITRK1 MET NDEL1 PTPRD MME FLRT1 GOLGA2 ZNF365 ROBO1 CAPRIN1 XRCC6 | 4.48e-04 | 418 | 214 | 13 | GO:0051962 |
| GeneOntologyBiologicalProcess | single strand break repair | 4.57e-04 | 15 | 214 | 3 | GO:0000012 | |
| GeneOntologyBiologicalProcess | embryonic hindlimb morphogenesis | 4.58e-04 | 35 | 214 | 4 | GO:0035116 | |
| GeneOntologyBiologicalProcess | circulatory system development | MYH11 CEACAM7 NEB TRIP11 ITGB3 NDUFV2 MET PTPRB PIK3R2 FGF8 PLEC STAB2 RPGRIP1L NRAP NEBL LAMA4 PCDHA10 APOB THBS1 SH3PXD2B LIPA NPHP3 XIRP2 SMARCA4 ROBO1 PDCD10 ENPEP SOD2 DNAH11 | 4.67e-04 | 1442 | 214 | 29 | GO:0072359 |
| GeneOntologyBiologicalProcess | cardiac septum development | 5.06e-04 | 134 | 214 | 7 | GO:0003279 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH11 CENPE SPTBN1 GAS8 RIBC1 TUBGCP4 NEB DCTN1 ZNF804A NDEL1 KRT77 PKP1 DLG1 FBXO32 PLEC DNAH6 GOLGA2 CNP FLNB COL6A3 KRT78 RPGRIP1L NRAP NEBL CFAP210 PPL LRPPRC XIRP2 TTLL4 DNAI2 LUM DNAH11 | 4.85e-07 | 1179 | 215 | 32 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH11 CENPE SPTBN1 GAS8 RIBC1 TUBGCP4 NEB DCTN1 ZNF804A NDEL1 KRT77 PKP1 DLG1 FBXO32 PLEC DNAH6 GOLGA2 CNP FLNB COL6A3 KRT78 RPGRIP1L NRAP NEBL CFAP210 PPL LRPPRC XIRP2 TTLL4 DNAI2 LUM DNAH11 | 5.62e-07 | 1187 | 215 | 32 | GO:0099081 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | DOCK4 MYH11 MYO3B MME PLEC FLNB TSPEAR SLC28A2 MTTP MYO15A ENPEP | 2.08e-05 | 223 | 215 | 11 | GO:0098862 |
| GeneOntologyCellularComponent | microtubule | CENPE GAS8 RIBC1 TUBGCP4 DCTN1 ZNF804A NDEL1 DLG1 DNAH6 GOLGA2 CNP RPGRIP1L CFAP210 LRPPRC TTLL4 DNAI2 DNAH11 | 3.96e-05 | 533 | 215 | 17 | GO:0005874 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | CENPE GAS8 RIBC1 TUBGCP4 DCTN1 ZNF804A NDEL1 KRT77 PKP1 DLG1 PLEC DNAH6 GOLGA2 CNP KRT78 RPGRIP1L CFAP210 PPL LRPPRC TTLL4 DNAI2 DNAH11 | 1.56e-04 | 899 | 215 | 22 | GO:0099513 |
| GeneOntologyCellularComponent | myelin sheath | 4.29e-04 | 217 | 215 | 9 | GO:0043209 | |
| MousePheno | bifid ureter | 1.09e-05 | 12 | 175 | 4 | MP:0003584 | |
| MousePheno | abnormal diencephalon morphology | CACNA2D2 PEG3 NAPA PLXNB2 PRDM2 FGF8 NPC1 RPGRIP1L HELQ OPHN1 SH3PXD2A WDFY3 XRCC6 SOD2 | 2.31e-05 | 298 | 175 | 14 | MP:0000830 |
| MousePheno | abnormal locomotor coordination | GDF5 ZBTB16 CACNA2D2 TRPC3 NAPA NEB DCTN1 PTPRD SACS VPS13A KEL GOLGA2 CNP NPC1 FLNB LAMA4 EPG5 NAPB NEMF MYO15A ANKFN1 MCOLN3 SOD2 | 3.76e-05 | 726 | 175 | 23 | MP:0003312 |
| MousePheno | abnormal muscle morphology | NCOA3 MYH11 CACNA2D2 SPTBN1 CEACAM7 NEB ITGB3 MET PTPRB SACS CIBAR1 FBXO32 PLEC COL6A3 RPGRIP1L NEBL LAMA4 EPG5 TMEM106B THBS1 SH3PXD2B XIRP2 SH3PXD2A NEMF ROBO1 WDFY3 LUM PDCD10 SOD2 DNAH11 | 4.37e-05 | 1106 | 175 | 30 | MP:0002108 |
| MousePheno | muscular ventricular septal defect | 4.92e-05 | 77 | 175 | 7 | MP:0010420 | |
| MousePheno | abnormal interventricular septum muscular part morphology | 5.80e-05 | 79 | 175 | 7 | MP:0010498 | |
| Domain | NSF_attach | 1.42e-06 | 3 | 211 | 3 | IPR000744 | |
| Domain | Nebulin | 5.64e-06 | 4 | 211 | 3 | PF00880 | |
| Domain | NEBULIN | 5.64e-06 | 4 | 211 | 3 | PS51216 | |
| Domain | NEBU | 5.64e-06 | 4 | 211 | 3 | SM00227 | |
| Domain | Nebulin | 5.64e-06 | 4 | 211 | 3 | IPR013998 | |
| Domain | Nebulin_repeat | 5.64e-06 | 4 | 211 | 3 | IPR000900 | |
| Domain | PolyA | 1.40e-05 | 5 | 211 | 3 | SM00517 | |
| Domain | - | 1.40e-05 | 5 | 211 | 3 | 1.10.1900.10 | |
| Domain | PABP | 1.40e-05 | 5 | 211 | 3 | PF00658 | |
| Domain | PABC | 1.40e-05 | 5 | 211 | 3 | PS51309 | |
| Domain | PABP_HYD | 1.40e-05 | 5 | 211 | 3 | IPR002004 | |
| Domain | TPR-like_helical_dom | SART3 SAMD9 TTC21A NAPG NAPA TTC3 EIF3L SEL1L LRPPRC NPHP3 NAPB P3H2 | 1.43e-05 | 233 | 211 | 12 | IPR011990 |
| Domain | - | 1.27e-04 | 207 | 211 | 10 | 1.25.40.10 | |
| Domain | Vitellinogen_b-sht_N | 1.27e-04 | 2 | 211 | 2 | IPR015816 | |
| Domain | Lipid_transp_b-sht_shell | 1.27e-04 | 2 | 211 | 2 | IPR015819 | |
| Domain | - | 1.27e-04 | 2 | 211 | 2 | 2.30.230.10 | |
| Domain | VITELLOGENIN | 1.27e-04 | 2 | 211 | 2 | PS51211 | |
| Domain | LPD_N | 1.27e-04 | 2 | 211 | 2 | SM00638 | |
| Domain | Lipid_transpt_N | 1.27e-04 | 2 | 211 | 2 | IPR001747 | |
| Domain | - | 1.27e-04 | 2 | 211 | 2 | 1.25.10.20 | |
| Domain | Vitellogenin_N | 1.27e-04 | 2 | 211 | 2 | PF01347 | |
| Domain | SH3 | DOCK4 NEB ARHGEF7 PIK3R2 DLG1 NEBL ARHGEF5 SH3PXD2B SH3PXD2A MYO15A | 1.79e-04 | 216 | 211 | 10 | SM00326 |
| Domain | SH3 | DOCK4 NEB ARHGEF7 PIK3R2 DLG1 NEBL ARHGEF5 SH3PXD2B SH3PXD2A MYO15A | 1.79e-04 | 216 | 211 | 10 | PS50002 |
| Domain | - | 1.89e-04 | 74 | 211 | 6 | 3.40.50.410 | |
| Domain | SH3_domain | DOCK4 NEB ARHGEF7 PIK3R2 DLG1 NEBL ARHGEF5 SH3PXD2B SH3PXD2A MYO15A | 2.08e-04 | 220 | 211 | 10 | IPR001452 |
| Domain | Spectrin_repeat | 3.01e-04 | 29 | 211 | 4 | IPR002017 | |
| Domain | PH_dom-like | NBEAL1 SPTBN1 JAK3 PTPN4 ARHGEF7 PREX1 ANKS1A RASA2 ARHGEF5 RALGPS2 ECT2 OPHN1 DCP1B WDFY3 | 3.63e-04 | 426 | 211 | 14 | IPR011993 |
| Domain | WGR | 3.78e-04 | 3 | 211 | 2 | SM00773 | |
| Domain | PARP_reg | 3.78e-04 | 3 | 211 | 2 | PF02877 | |
| Domain | WGR | 3.78e-04 | 3 | 211 | 2 | PF05406 | |
| Domain | Vitellinogen_superhlx | 3.78e-04 | 3 | 211 | 2 | IPR011030 | |
| Domain | PPR_3 | 3.78e-04 | 3 | 211 | 2 | PF13812 | |
| Domain | - | 3.78e-04 | 3 | 211 | 2 | 2.20.140.10 | |
| Domain | SH3_2 | 4.29e-04 | 86 | 211 | 6 | PF07653 | |
| Domain | SH3_2 | 4.29e-04 | 86 | 211 | 6 | IPR011511 | |
| Domain | SPEC | 4.44e-04 | 32 | 211 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 4.44e-04 | 32 | 211 | 4 | IPR018159 | |
| Domain | Laminin_G | 4.94e-04 | 58 | 211 | 5 | IPR001791 | |
| Domain | SH3_1 | 5.63e-04 | 164 | 211 | 8 | PF00018 | |
| Domain | PTPc | 7.02e-04 | 36 | 211 | 4 | SM00194 | |
| Domain | - | 7.30e-04 | 95 | 211 | 6 | 2.60.120.200 | |
| Domain | VDCC_a2/dsu | 7.51e-04 | 4 | 211 | 2 | IPR013680 | |
| Domain | PARP_ALPHA_HD | 7.51e-04 | 4 | 211 | 2 | PS51060 | |
| Domain | Poly(ADP-ribose)pol_reg_dom | 7.51e-04 | 4 | 211 | 2 | IPR004102 | |
| Domain | VGCC_alpha2 | 7.51e-04 | 4 | 211 | 2 | PF08473 | |
| Domain | - | 7.51e-04 | 4 | 211 | 2 | 1.20.142.10 | |
| Domain | VWF_A | 9.07e-04 | 99 | 211 | 6 | IPR002035 | |
| Domain | GDS_CDC24_CS | 9.55e-04 | 39 | 211 | 4 | IPR001331 | |
| Domain | TYR_PHOSPHATASE_PTP | 9.55e-04 | 39 | 211 | 4 | PS50055 | |
| Domain | PTPase_domain | 1.16e-03 | 41 | 211 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 1.16e-03 | 41 | 211 | 4 | PF00102 | |
| Domain | VWA_N | 1.24e-03 | 5 | 211 | 2 | IPR013608 | |
| Domain | SMC | 1.24e-03 | 5 | 211 | 2 | IPR024704 | |
| Domain | VWA_N | 1.24e-03 | 5 | 211 | 2 | PF08399 | |
| Domain | PABP_1234 | 1.24e-03 | 5 | 211 | 2 | IPR006515 | |
| Domain | DUF4704 | 1.24e-03 | 5 | 211 | 2 | IPR031570 | |
| Domain | DUF4704 | 1.24e-03 | 5 | 211 | 2 | PF15787 | |
| Domain | LamG | 1.51e-03 | 44 | 211 | 4 | SM00282 | |
| Domain | TRP_2 | 1.85e-03 | 6 | 211 | 2 | PF08344 | |
| Domain | SMC_hinge | 1.85e-03 | 6 | 211 | 2 | SM00968 | |
| Domain | PH_BEACH | 1.85e-03 | 6 | 211 | 2 | PF14844 | |
| Domain | TRP_dom | 1.85e-03 | 6 | 211 | 2 | IPR013555 | |
| Domain | SMC_hinge | 1.85e-03 | 6 | 211 | 2 | PF06470 | |
| Domain | SMC_hinge | 1.85e-03 | 6 | 211 | 2 | IPR010935 | |
| Domain | ACTININ_2 | 2.13e-03 | 23 | 211 | 3 | PS00020 | |
| Domain | ACTININ_1 | 2.13e-03 | 23 | 211 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.13e-03 | 23 | 211 | 3 | IPR001589 | |
| Domain | VWFA | 2.37e-03 | 82 | 211 | 5 | PS50234 | |
| Domain | STAT_TF_DNA-bd_sub | 2.57e-03 | 7 | 211 | 2 | IPR012345 | |
| Domain | STAT | 2.57e-03 | 7 | 211 | 2 | IPR001217 | |
| Domain | STAT_int | 2.57e-03 | 7 | 211 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 2.57e-03 | 7 | 211 | 2 | IPR013801 | |
| Domain | STAT_bind | 2.57e-03 | 7 | 211 | 2 | PF02864 | |
| Domain | Peptidase_M13_C | 2.57e-03 | 7 | 211 | 2 | IPR018497 | |
| Domain | STAT_int | 2.57e-03 | 7 | 211 | 2 | PF02865 | |
| Domain | Plectin | 2.57e-03 | 7 | 211 | 2 | PF00681 | |
| Domain | Peptidase_M13 | 2.57e-03 | 7 | 211 | 2 | IPR000718 | |
| Domain | Peptidase_M13_N | 2.57e-03 | 7 | 211 | 2 | PF05649 | |
| Domain | - | 2.57e-03 | 7 | 211 | 2 | 1.10.532.10 | |
| Domain | Peptidase_M13_N | 2.57e-03 | 7 | 211 | 2 | IPR008753 | |
| Domain | STAT_alpha | 2.57e-03 | 7 | 211 | 2 | PF01017 | |
| Domain | TRPC_channel | 2.57e-03 | 7 | 211 | 2 | IPR002153 | |
| Domain | - | 2.57e-03 | 7 | 211 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 2.57e-03 | 7 | 211 | 2 | IPR013799 | |
| Domain | Plectin_repeat | 2.57e-03 | 7 | 211 | 2 | IPR001101 | |
| Domain | STAT_TF_coiled-coil | 2.57e-03 | 7 | 211 | 2 | IPR015988 | |
| Domain | - | 2.57e-03 | 7 | 211 | 2 | 2.60.40.630 | |
| Domain | Peptidase_M13 | 2.57e-03 | 7 | 211 | 2 | PF01431 | |
| Domain | PLEC | 2.57e-03 | 7 | 211 | 2 | SM00250 | |
| Domain | VWA | 2.63e-03 | 84 | 211 | 5 | SM00327 | |
| Domain | ERAP1-like_C_dom | 3.40e-03 | 8 | 211 | 2 | IPR024571 | |
| Domain | STAT_TF_alpha | 3.40e-03 | 8 | 211 | 2 | IPR013800 | |
| Domain | PH-BEACH_dom | 3.40e-03 | 8 | 211 | 2 | IPR023362 | |
| Domain | ERAP1_C | 3.40e-03 | 8 | 211 | 2 | PF11838 | |
| Domain | - | 3.40e-03 | 8 | 211 | 2 | 2.30.29.40 | |
| Domain | PPR | 3.40e-03 | 8 | 211 | 2 | PS51375 | |
| Domain | RecF/RecN/SMC_N | 3.40e-03 | 8 | 211 | 2 | IPR003395 | |
| Domain | PH_BEACH | 3.40e-03 | 8 | 211 | 2 | PS51783 | |
| Domain | SMC_N | 3.40e-03 | 8 | 211 | 2 | PF02463 | |
| Domain | HECT | 3.40e-03 | 27 | 211 | 3 | PF00632 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 1.44e-05 | 5 | 161 | 3 | M48987 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 2.03e-05 | 15 | 161 | 4 | MM14536 | |
| Pathway | REACTOME_LDL_REMODELING | 2.85e-05 | 6 | 161 | 3 | M42520 | |
| Pathway | WP_IL9_SIGNALING | 3.47e-05 | 17 | 161 | 4 | M39644 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 4.95e-05 | 7 | 161 | 3 | M47581 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 5.17e-05 | 36 | 161 | 5 | M542 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 5.56e-05 | 19 | 161 | 4 | M41732 | |
| Pathway | REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES | 7.85e-05 | 8 | 161 | 3 | MM14895 | |
| Pathway | PID_TCPTP_PATHWAY | 1.10e-04 | 42 | 161 | 5 | M91 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.17e-04 | 9 | 161 | 3 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.17e-04 | 9 | 161 | 3 | M8066 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.17e-04 | 9 | 161 | 3 | MM1419 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 1.23e-04 | 23 | 161 | 4 | MM1411 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.65e-04 | 10 | 161 | 3 | M27898 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | GDF5 MATN3 ITGB3 FGB PLEC COL6A3 LAMA4 THBS1 SH3PXD2A P3H2 CD151 LUM | 1.71e-04 | 300 | 161 | 12 | M610 |
| Pathway | WP_IL7_SIGNALING | 1.72e-04 | 25 | 161 | 4 | M39499 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | GDF5 MATN3 CEACAM7 ITGB3 FGB COL6A3 LAMA4 THBS1 SH3PXD2A P3H2 LUM | 1.85e-04 | 258 | 161 | 11 | MM14572 |
| Pathway | REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES | 2.26e-04 | 11 | 161 | 3 | M27182 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 2.34e-04 | 27 | 161 | 4 | M47755 | |
| Pathway | REACTOME_FLT3_SIGNALING_IN_DISEASE | 2.71e-04 | 28 | 161 | 4 | M41724 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 2.98e-04 | 12 | 161 | 3 | M27893 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.74e-04 | 57 | 161 | 5 | MM14713 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 4.85e-04 | 14 | 161 | 3 | M27858 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 5.13e-04 | 58 | 161 | 5 | M2049 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 5.21e-04 | 202 | 161 | 9 | MM15362 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 5.60e-04 | 204 | 161 | 9 | M4217 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 6.01e-04 | 15 | 161 | 3 | M552 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 7.34e-04 | 16 | 161 | 3 | MM15605 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 7.34e-04 | 16 | 161 | 3 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 7.34e-04 | 16 | 161 | 3 | MM1420 | |
| Pathway | REACTOME_INTRA_GOLGI_TRAFFIC | 8.07e-04 | 37 | 161 | 4 | MM15354 | |
| Pubmed | CEP104 SART3 MYH11 CENPC SPTBN1 CAGE1 ASIC5 NEB TTC3 DCTN1 NDUFV2 PARP1 SACS TCHHL1 KRT77 VPS13A DLG1 PLEC DNAH6 PREX1 ERICH6 FLNB SMC4 CCDC150 APOB CFAP210 SMC2 PPL LRPPRC SH3PXD2A PABPC3 MTTP PABPC1L XRCC6 PCID2 ATP5F1C | 1.10e-12 | 1442 | 216 | 36 | 35575683 | |
| Pubmed | ZBTB16 REPS1 SPTBN1 PEG3 NEB TTC3 DCTN1 TRIP11 PUM3 FBXO32 PLEC FLNB COL6A3 NRAP LAMA4 ECT2 LRPPRC NPHP3 XIRP2 XRCC6 | 5.30e-11 | 497 | 216 | 20 | 23414517 | |
| Pubmed | TPP2 NCOA3 CENPE SPTBN1 TTC3 DCTN1 TRIP11 PARP1 CNTNAP5 PTPRD UBR5 ARHGEF7 DLG1 GOLGA2 CNP ANKS1A CACNA2D1 SMC2 LRPPRC SH3PXD2B PABPC3 CSNK2A2 SMARCA4 WDFY3 CAPRIN1 XRCC6 | 3.96e-10 | 963 | 216 | 26 | 28671696 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | RIDA MATN3 SPTBN1 CCDC18 NHLRC2 TIMMDC1 PLXNB2 DCTN1 PTPRD ARHGEF7 PIK3R2 CIBAR1 VPS13A SEL1L RPGRIP1L NEBL C19orf67 USP24 RALGPS2 ANO10 ZNF365 ANKRD13A LRPPRC ELL2 SH3PXD2A TTLL4 PABPC1L MYO15A | 4.37e-09 | 1242 | 216 | 28 | 30973865 |
| Pubmed | SART3 TPP2 MYH11 BTBD8 TTC21A SPTBN1 DCTN1 TRIP11 NDUFV2 PARP1 NDEL1 SACS EIF3L DLG1 PLEC DNAH6 CNP PTCD3 FLNB CACNA2D1 KRT78 OPHN1 LRPPRC NAPB PABPC3 CSNK2A2 SMARCA4 CAPRIN1 ATP5F1C DNAH11 | 6.12e-09 | 1431 | 216 | 30 | 37142655 | |
| Pubmed | REPS1 DIS3L SPTBN1 PEG3 NAPA TTC3 DCTN1 TRIP11 STAT5B PARP1 PTPRD SACS DLG1 PLEC PREX1 NPC1 FLNB ZNF365 THBS1 RPRD1A NAPB HECTD2 NEMF SMARCA4 ROBO1 WDFY3 CAPRIN1 XRCC6 | 9.09e-09 | 1285 | 216 | 28 | 35914814 | |
| Pubmed | GAS8 TTC3 TRIP11 NDUFV2 FGB DLG1 FGF8 NPC1 NEBL RALGPS2 ANO10 ANKRD13A TMEM106B THBS1 NPHP3 DCP1B RASSF6 TMEM87B CSNK2A2 MCOLN3 | 1.33e-08 | 686 | 216 | 20 | 29987050 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 CENPC SPTBN1 DCTN1 PARP1 UBR5 EIF3L PKP1 PUM3 PLEC CNP PTCD3 USP36 CUL1 FLNB RASA2 POLA1 SMC4 SMC2 ECT2 CCNT1 LRPPRC SMARCA4 WDFY3 CAPRIN1 XRCC6 PCID2 ATP5F1C | 2.71e-08 | 1353 | 216 | 28 | 29467282 |
| Pubmed | CEP104 SPTBN1 PEG3 PRDM2 CIBAR1 KRT77 PKP1 PLEC PZP POLA1 ARHGEF5 TEX15 SMC2 | 3.09e-08 | 284 | 216 | 13 | 29459677 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | PARP1 PIK3R2 CNP CUL1 SMC4 SMC2 LRPPRC SH3PXD2B TTLL4 NEMF SMARCA4 CAPRIN1 CWF19L1 XRCC6 HERC5 ATP5F1C | 7.79e-08 | 486 | 216 | 16 | 30940648 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SART3 TPP2 MYH11 SPTBN1 DCTN1 ZNF804A PARP1 EIF3L PLEC DNAH6 PTCD3 CUL1 FLNB PARP3 SMC4 SMC2 PABPC3 SMARCA4 CAPRIN1 XRCC6 ATP5F1C | 8.97e-08 | 847 | 216 | 21 | 35235311 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SART3 SAMD9 SPTBN1 PARP1 KRT77 EIF3L PKP1 DLG1 PUM3 PLEC GOLGA2 CNP PTCD3 FLNB KRT78 SMC4 SMC2 ECT2 PPL LRPPRC THBS1 CSNK2A2 SMARCA4 CAPRIN1 XRCC6 ATP5F1C | 8.98e-08 | 1257 | 216 | 26 | 36526897 |
| Pubmed | 1.17e-07 | 128 | 216 | 9 | 23858473 | ||
| Pubmed | SART3 SPTBN1 DCTN1 PARP1 EIF3L PLEC CNP CUL1 FLNB POLA1 USP24 SMC4 SMC2 LRPPRC RPRD1A SMARCA4 XRCC6 ATP5F1C | 1.19e-07 | 638 | 216 | 18 | 33239621 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DOCK4 SART3 GAS8 DCTN1 MET UBR5 ARHGEF7 KRT77 EIF3L PREX1 PTCD3 ANKS1A CUL1 KRT78 UFC1 PARP3 RALGPS2 SMC4 SMC2 LRPPRC CSNK2A2 SMARCA4 PDCD10 CAPRIN1 PCID2 SOD2 | 1.36e-07 | 1284 | 216 | 26 | 17353931 |
| Pubmed | SART3 TPP2 SPTBN1 UBR5 EIF3L PUM3 PLEC PTCD3 FLNB POLA1 USP24 SMC4 LRPPRC CSNK2A2 SMARCA4 CAPRIN1 XRCC6 HERC5 | 1.68e-07 | 653 | 216 | 18 | 22586326 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SART3 NCOA3 ZNF609 TTC21A TUBGCP4 DCTN1 TRIP11 NDEL1 EIF3L PLEC CNP RPGRIP1L WRN RALGPS2 SMC4 CCDC150 SMC2 ECT2 ANKRD13A LRPPRC LSM6 NPHP3 RPRD1A DCP1B SH3PXD2A LUM | 2.34e-07 | 1321 | 216 | 26 | 27173435 |
| Pubmed | SNAP family of NSF attachment proteins includes a brain-specific isoform. | 2.36e-07 | 3 | 216 | 3 | 8455721 | |
| Pubmed | 2.36e-07 | 3 | 216 | 3 | 9695844 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SART3 TPP2 SPTBN1 DCTN1 PARP1 UBR5 ARHGEF7 EIF3L PKP1 PPIL2 PLEC GOLGA2 CNP PTCD3 FLNB POLA1 USP24 SMC4 SMC2 LRPPRC CSNK2A2 NEMF SMARCA4 CAPRIN1 CWF19L1 XRCC6 ATP5F1C | 2.48e-07 | 1415 | 216 | 27 | 28515276 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MYH11 NAPA PTPRD KRT77 FGB MME PZP CNP TRHDE FLNB COL6A3 CACNA2D1 STEAP4 APOB THBS1 NAPB PABPC3 CNDP2 PABPC1L LUM PDCD10 ENPEP SOD2 | 2.69e-07 | 1070 | 216 | 23 | 23533145 |
| Pubmed | SPTBN1 PARP1 UBR5 GOLGA2 NPC1 CUL1 FLNB POLA1 SMC4 SMC2 ECT2 LRPPRC RPRD1A CNDP2 XRCC6 SOD2 | 3.06e-07 | 538 | 216 | 16 | 28524877 | |
| Pubmed | SART3 TPP2 REPS1 SPTBN1 NAPG NAPA TUBGCP4 PARP1 UBR5 EIF3L PUM3 STX7 CNP PTCD3 SEL1L CUL1 FLNB CACNA2D1 SMC4 SMC2 ANKRD13A LRPPRC CSNK2A2 CAPRIN1 XRCC6 HERC5 ATP5F1C | 3.49e-07 | 1440 | 216 | 27 | 30833792 | |
| Pubmed | SART3 MYH11 REPS1 SPTBN1 PEG3 NAPA WDR76 PARP1 TCHHL1 KRT77 PUM3 PLEC GOLGA2 CNP ZNF574 PTCD3 CUL1 WRN APOB MED19 CSNK2A2 NEMF SMARCA4 FBXO21 CAPRIN1 XRCC6 | 4.74e-07 | 1371 | 216 | 26 | 36244648 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 6.11e-07 | 202 | 216 | 10 | 33005030 | |
| Pubmed | Genetic influences on lipid metabolism trait variability within the Stanislas Cohort. | 6.89e-07 | 12 | 216 | 4 | 11714857 | |
| Pubmed | SART3 ZNF609 SAMD9 TUBGCP4 ITGB3 STAT5B ARHGEF7 DLG1 PZP GOLGA2 ZNF574 ARHGEF5 SMC2 ECT2 NEMF CWF19L1 ATP5F1C | 7.71e-07 | 650 | 216 | 17 | 38777146 | |
| Pubmed | WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation. | 8.59e-07 | 52 | 216 | 6 | 30655611 | |
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 28930659 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 14734561 | ||
| Pubmed | HIV-1 NL4-3, but not IIIB, inhibits JAK3/STAT5 activation in CD4(+) T cells. | 9.41e-07 | 4 | 216 | 3 | 11485409 | |
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 12605694 | ||
| Pubmed | 9.41e-07 | 4 | 216 | 3 | 23985323 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 CACNA2D2 SPTBN1 TTC3 DCTN1 PRDM2 PARP1 EIF3L PKP1 PUM3 PTCD3 USP36 CUL1 FLNB POLA1 SMC4 APOB SMC2 LRPPRC RPRD1A CSNK2A2 NEMF SMARCA4 CAPRIN1 XRCC6 ATP5F1C | 9.75e-07 | 1425 | 216 | 26 | 30948266 |
| Pubmed | Genetic influences on blood pressure within the Stanislas Cohort. | 9.90e-07 | 13 | 216 | 4 | 15076187 | |
| Pubmed | MYH11 SPTBN1 NAPA PARP1 CUL1 POLA1 WRN SMC4 SMC2 CSNK2A2 CAPRIN1 XRCC6 | 1.67e-06 | 340 | 216 | 12 | 24332808 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | RIDA SPTBN1 NAPG NAPA NEB MME CNP NPC1 FLNB COL6A3 CACNA2D1 NEBL UFC1 SMC2 PPL THBS1 CNDP2 MYO15A PDCD10 EPCAM ENPEP | 1.70e-06 | 1016 | 216 | 21 | 19056867 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | SPTBN1 ITGB3 PARP1 PLEC FLNB USP24 SMC4 SMC2 SH3PXD2B PABPC3 CNDP2 CAPRIN1 | 1.89e-06 | 344 | 216 | 12 | 30333137 |
| Pubmed | SART3 CENPC SPTBN1 CCDC18 TTC3 TIMMDC1 PLXNB2 DCTN1 NDUFV2 EFR3A MET PARP1 SACS UBR5 PIK3R2 VPS13A DLG1 STX7 PTCD3 PDPR LRPPRC CNDP2 ROBO1 CAPRIN1 XRCC6 HERC5 | 2.13e-06 | 1487 | 216 | 26 | 33957083 | |
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 18549798 | ||
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 9047382 | ||
| Pubmed | Stat5a/b are essential for normal lymphoid development and differentiation. | 2.34e-06 | 5 | 216 | 3 | 16418296 | |
| Pubmed | 2.34e-06 | 5 | 216 | 3 | 1315316 | ||
| Pubmed | Direct interaction between Kit and the interleukin-7 receptor. | 2.34e-06 | 5 | 216 | 3 | 17554063 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 2.40e-06 | 235 | 216 | 10 | 30258100 | |
| Pubmed | SAMD9 NAPA DCTN1 PARP1 KRT77 EIF3L PLEC FLNB SMC4 SMC2 LRPPRC SH3PXD2A NEMF CNDP2 SMARCA4 CAPRIN1 XRCC6 ATP5F1C | 3.20e-06 | 803 | 216 | 18 | 36517590 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH11 SPTBN1 DCTN1 UBR5 EIF3L PLEC PZP PTCD3 FLNB SMC4 ANKRD13A LRPPRC PABPC3 PABPC1L FBXO21 EPCAM | 3.36e-06 | 647 | 216 | 16 | 26618866 |
| Pubmed | ZNF609 REPS1 SPTBN1 TUBGCP4 DCTN1 PARP1 PIK3R2 DLG1 PPIL2 GOLGA2 CUL1 NEBL SMC4 SMC2 CCNT1 LRPPRC ELL2 NEMF CNDP2 CAPRIN1 XRCC6 PCID2 ATP5F1C | 3.61e-06 | 1247 | 216 | 23 | 27684187 | |
| Pubmed | RIDA BTBD8 NBEAL1 PTPN22 ZNF804A PTPRD MYO3B PUM3 PZP DEUP1 ANKS1A CACNA2D1 SLC35A1 ANO10 ECT2 DCP1B CD151 MYO15A | 3.86e-06 | 814 | 216 | 18 | 23251661 | |
| Pubmed | Protein phosphatase 2A regulates interleukin-2 receptor complex formation and JAK3/STAT5 activation. | 4.66e-06 | 6 | 216 | 3 | 19923221 | |
| Pubmed | Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. | 4.66e-06 | 6 | 216 | 3 | 10485657 | |
| Pubmed | 4.66e-06 | 6 | 216 | 3 | 24166977 | ||
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | REPS1 MET PTPRD PIK3R2 VPS13A PTCD3 ARHGEF5 APOB LRPPRC ATP5F1C | 5.13e-06 | 256 | 216 | 10 | 24189400 |
| Pubmed | DOCK4 REPS1 BTBD8 ARHGEF7 PIK3R2 DLG1 PLEC PREX1 ARHGEF5 SMC4 ECT2 OPHN1 CCNT1 RPRD1A SH3PXD2A SMARCA4 ROBO1 PDCD10 ATP5F1C | 5.17e-06 | 916 | 216 | 19 | 32203420 | |
| Pubmed | 5.31e-06 | 257 | 216 | 10 | 16335952 | ||
| Pubmed | TPP2 PLXNB2 MET PARP1 UBR5 EIF3L CNP NPC1 SEL1L FLNB CACNA2D1 USP24 SMC4 APOB TMEM106B LRPPRC CSNK2A2 NEMF ROBO1 CAPRIN1 XRCC6 PCID2 ATP5F1C | 6.84e-06 | 1297 | 216 | 23 | 33545068 | |
| Pubmed | SPTBN1 PLXNB2 NDUFV2 PARP1 PTPRD MME STX7 CACNA2D1 NEBL LAMA4 TMEM106B LRPPRC P3H2 LUM CAPRIN1 XRCC6 SOD2 ATP5F1C | 8.05e-06 | 859 | 216 | 18 | 31536960 | |
| Pubmed | SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. | 8.12e-06 | 7 | 216 | 3 | 10490100 | |
| Pubmed | SPTBN1 TTC3 DCTN1 PARP1 SACS PLEC FLNB THBS1 SH3PXD2B LIPA SMARCA4 | 8.27e-06 | 332 | 216 | 11 | 37433992 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 8.45e-06 | 271 | 216 | 10 | 32433965 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | TPP2 SPTBN1 PTPRB PLEC TRHDE FLNB SMC4 LRPPRC SH3PXD2B CAPRIN1 XRCC6 | 8.51e-06 | 333 | 216 | 11 | 32665550 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NCOA3 MYH11 SPTBN1 DCTN1 PARP1 EIF3L PPIL2 PLEC CUL1 FLNB SMC4 APOB ECT2 LRPPRC SMARCA4 CAPRIN1 XRCC6 HERC5 ATP5F1C | 8.51e-06 | 949 | 216 | 19 | 36574265 |
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 9.84e-06 | 218 | 216 | 9 | 35831895 | |
| Pubmed | SART3 ZNF609 CENPC NHLRC2 TIMMDC1 DCTN1 PARP1 UBR5 ARHGEF7 PIK3R2 PUM3 PPIL2 ZNF574 ANKS1A SEL1L POLA1 UFC1 SLC35A1 LSM6 RPRD1A FBXO21 CAPRIN1 SOD2 | 9.87e-06 | 1327 | 216 | 23 | 32694731 | |
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 1.02e-05 | 79 | 216 | 6 | 26446488 | |
| Pubmed | 1.19e-05 | 282 | 216 | 10 | 23667531 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SART3 ZNF609 CENPC CENPE TUBGCP4 DCTN1 NDEL1 UBR5 EIF3L FGB GOLGA2 PTCD3 CACNA2D1 CENPU ECT2 PPL THBS1 SMARCA4 PDCD10 CAPRIN1 XRCC6 | 1.21e-05 | 1155 | 216 | 21 | 20360068 |
| Pubmed | SPTBN1 DCTN1 PARP1 VNN2 EIF3L DLG1 PLEC GOLGA2 PTCD3 CUL1 SMC4 SMC2 CCNT1 LRPPRC PDCD10 CAPRIN1 XRCC6 | 1.40e-05 | 809 | 216 | 17 | 32129710 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 1.48e-05 | 175 | 216 | 8 | 25756610 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CENPE MATN3 SPTBN1 PTPN22 NEB SLITRK1 STAT5A PTPRB FGB GOLGA2 CUL1 SMC4 XIRP2 | 1.58e-05 | 497 | 216 | 13 | 36774506 |
| Pubmed | SPTBN1 PEG3 ZNF267 TTC3 DCTN1 PRDM2 DLG1 PLEC NPC1 FLNB RASA2 RALGPS2 ZNF507 SLC35A1 APOB SH3PXD2B NPHP3 CSNK2A2 TTLL4 PDCD10 | 1.60e-05 | 1084 | 216 | 20 | 11544199 | |
| Pubmed | SPTBN1 TRIP11 ITGB3 MET PTPRB PLEC GOLGA2 PTCD3 FLNB PPL CNDP2 | 1.76e-05 | 360 | 216 | 11 | 33111431 | |
| Pubmed | 1.78e-05 | 87 | 216 | 6 | 24169447 | ||
| Pubmed | 1.81e-05 | 52 | 216 | 5 | 23182705 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | SART3 PARP1 KLHL9 UBR5 KRT77 EIF3L PKP1 DLG1 PLEC USP36 CUL1 FLNB POLA1 WRN CENPU LRPPRC LSM6 DCP1B CSNK2A2 | 1.88e-05 | 1005 | 216 | 19 | 19615732 |
| Pubmed | 1.93e-05 | 9 | 216 | 3 | 23435120 | ||
| Pubmed | 1.93e-05 | 9 | 216 | 3 | 10781830 | ||
| Pubmed | Impact of genetic polymorphisms on platelet function and aspirin resistance. | 1.93e-05 | 9 | 216 | 3 | 19923980 | |
| Pubmed | Seven novel mammalian SNARE proteins localize to distinct membrane compartments. | 1.93e-05 | 9 | 216 | 3 | 9553086 | |
| Pubmed | TPP2 NCOA3 ZNF609 PTPN22 PRDM2 PARP1 UBR5 SEPTIN14 PUM3 PPIL2 CUL1 ZNF507 SMC4 SMC2 CCNT1 LSM6 CSNK2A2 SMARCA4 CAPRIN1 XRCC6 | 2.05e-05 | 1103 | 216 | 20 | 34189442 | |
| Pubmed | SART3 NCOA3 CENPC PARP1 UBR5 EIF3L PLEC CUL1 POLA1 SMC4 SMC2 CCNT1 MED19 CSNK2A2 CNDP2 SMARCA4 MYO15A CWF19L1 XRCC6 | 2.13e-05 | 1014 | 216 | 19 | 32416067 | |
| Pubmed | 2.18e-05 | 54 | 216 | 5 | 35474131 | ||
| Pubmed | ZBTB16 SPTBN1 TTC3 DCTN1 UBR5 EIF3L PLEC FLNB LAMA4 PPL EPG5 ANKRD13A DCP1B XRCC6 | 2.24e-05 | 591 | 216 | 14 | 15231748 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PLXNB2 PARP1 SACS UBR5 KRT77 PKP1 PUM3 PLEC STX7 CNP FLNB CACNA2D1 KRT78 SMC4 SMC2 LRPPRC SMARCA4 XRCC6 ATP5F1C | 2.43e-05 | 1024 | 216 | 19 | 24711643 |
| Pubmed | 2.45e-05 | 92 | 216 | 6 | 20301317 | ||
| Pubmed | 2.64e-05 | 28 | 216 | 4 | 18067320 | ||
| Pubmed | TERRA transcripts are bound by a complex array of RNA-binding proteins. | 2.64e-05 | 28 | 216 | 4 | 20975687 | |
| Pubmed | Structure of the mouse Stat 3/5 locus: evolution from Drosophila to zebrafish to mouse. | 2.75e-05 | 10 | 216 | 3 | 11161808 | |
| Pubmed | 2.75e-05 | 10 | 216 | 3 | 20974963 | ||
| Pubmed | 2.75e-05 | 10 | 216 | 3 | 10200816 | ||
| Pubmed | 2.75e-05 | 10 | 216 | 3 | 19072566 | ||
| Pubmed | 2.75e-05 | 10 | 216 | 3 | 19906129 | ||
| Pubmed | 2.75e-05 | 10 | 216 | 3 | 12082590 | ||
| Pubmed | Vascular at-risk genotypes and disease severity in Lebanese sickle cell disease patients. | 2.75e-05 | 10 | 216 | 3 | 20425806 | |
| Pubmed | 2.75e-05 | 10 | 216 | 3 | 17111197 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | SART3 PLXNB2 CACNA2D1 SMC4 SMC2 ANKRD13A CCNT1 NPHP3 CSNK2A2 CWF19L1 | 2.91e-05 | 313 | 216 | 10 | 38270169 |
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 23151802 | ||
| Pubmed | 3.84e-05 | 2 | 216 | 2 | 24799499 | ||
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 3.84e-05 | 2 | 216 | 2 | 31443474 | |
| Pubmed | Condensin mutations and abnormal chromosomal structures in pyothorax-associated lymphoma. | 3.84e-05 | 2 | 216 | 2 | 17488335 | |
| Interaction | YWHAZ interactions | MYH11 SPTBN1 CCDC18 NEB WDR76 DCTN1 PTPN4 NDEL1 ARHGEF7 PIK3R2 KRT77 PUM3 FBXO32 PLEC CNP ANKS1A RAD52 CUL1 KRT78 RPGRIP1L ARHGEF5 RALGPS2 SMC2 ECT2 LRPPRC RPRD1A DCP1B SH3PXD2A CSNK2A2 WDFY3 EPCAM CWF19L1 XRCC6 | 3.74e-06 | 1319 | 214 | 33 | int:YWHAZ |
| Interaction | MYH9 interactions | NCOA3 MYH11 SAMD9 SPTBN1 HMGCS2 WDR76 ITGB3 PIK3R2 MME PLEC DNAH6 SEL1L USP36 CUL1 FLNB SMC4 APOB SMC2 ECT2 LRPPRC THBS1 CAPRIN1 XRCC6 | 5.79e-06 | 754 | 214 | 23 | int:MYH9 |
| Interaction | ITGB2 interactions | 1.19e-05 | 132 | 214 | 9 | int:ITGB2 | |
| Interaction | LRRC31 interactions | MYH11 PARP1 PLEC FLNB KRT78 WRN SMC4 THBS1 MTTP CAPRIN1 XRCC6 | 1.27e-05 | 205 | 214 | 11 | int:LRRC31 |
| Interaction | KIF23 interactions | MYH11 SPTBN1 EFR3A PARP1 UBR5 EIF3L PUM3 MME PLEC CUL1 FLNB RPGRIP1L SMC4 CENPU SMC2 ECT2 LRPPRC ELL2 PABPC3 CSNK2A2 PABPC1L LRRC8B FBXO21 CAPRIN1 XRCC6 HERC5 ATP5F1C | 1.41e-05 | 1031 | 214 | 27 | int:KIF23 |
| Interaction | DSCAM interactions | 1.51e-05 | 171 | 214 | 10 | int:DSCAM | |
| Interaction | PGR interactions | 3.13e-05 | 84 | 214 | 7 | int:PGR | |
| Interaction | AFF4 interactions | 3.17e-05 | 115 | 214 | 8 | int:AFF4 | |
| Interaction | MYH10 interactions | MYH11 WDR76 ITGB3 PARP1 PIK3R2 GOLGA2 NPC1 CUL1 SMC4 SMC2 ASB12 ECT2 CAPRIN1 XRCC6 | 3.18e-05 | 359 | 214 | 14 | int:MYH10 |
| Interaction | CRK interactions | REPS1 PTPN22 ZNF804A STAT5A STAT5B MET PTPN4 PIK3R2 KRT77 PLEC KRT78 ARHGEF5 CNDP2 XRCC6 | 4.42e-05 | 370 | 214 | 14 | int:CRK |
| Interaction | BRD7 interactions | WDR76 PARP1 PIK3R2 CNP CUL1 USP24 SMC4 LAMA4 SMC2 LRPPRC SH3PXD2B TTLL4 NEMF SMARCA4 CAPRIN1 CWF19L1 XRCC6 HERC5 ATP5F1C | 5.28e-05 | 637 | 214 | 19 | int:BRD7 |
| Interaction | KIF20A interactions | MYH11 CENPE SPTBN1 TLR6 DCTN1 TRIP11 EFR3A PCNX2 PARP1 UBR5 MYO3B PUM3 PLEC SEL1L FLNB NEBL APOB CFAP210 PPL LRPPRC PABPC3 SMARCA4 PABPC1L CAPRIN1 XRCC6 ATP5F1C | 5.45e-05 | 1052 | 214 | 26 | int:KIF20A |
| Cytoband | 15q15 | 2.19e-05 | 12 | 216 | 3 | 15q15 | |
| Cytoband | 2p24-p23 | 2.20e-05 | 2 | 216 | 2 | 2p24-p23 | |
| Cytoband | 12p13-p12.2 | 2.20e-05 | 2 | 216 | 2 | 12p13-p12.2 | |
| Cytoband | 12q15-q21 | 6.59e-05 | 3 | 216 | 2 | 12q15-q21 | |
| GeneFamily | Dyneins, axonemal | 2.74e-04 | 17 | 138 | 3 | 536 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.98e-04 | 394 | 138 | 10 | 471 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 1.18e-03 | 7 | 138 | 2 | 761 | |
| GeneFamily | Transient receptor potential cation channels | 1.24e-03 | 28 | 138 | 3 | 249 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.57e-03 | 8 | 138 | 2 | 939 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.62e-03 | 66 | 138 | 4 | 722 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.01e-03 | 9 | 138 | 2 | 1230 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | DOCK4 CENPE SPTBN1 ARHGEF7 DLG1 PREX1 FLNB RASA2 SMC4 ECT2 OPHN1 LRPPRC | 1.07e-07 | 199 | 216 | 12 | M5893 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | DOCK4 RIDA CENPE CCDC18 ZNF267 TUBGCP4 TIMMDC1 SACS ETNK1 PTCD3 NPC1 CUL1 COL6A3 CACNA2D1 POLA1 WRN SMC4 CENPU CCDC150 LAMA4 SMC2 ECT2 CCNT1 LRPPRC LSM6 RPRD1A TTLL4 SMARCA4 ROBO1 CAPRIN1 XRCC6 | 5.90e-07 | 1407 | 216 | 31 | M14427 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | DOCK4 SART3 NCOA3 CENPC KLHL9 SACS UBR5 ARHGEF7 VPS13A CUL1 USP24 SMC4 WDFY3 | 1.39e-06 | 300 | 216 | 13 | M8702 |
| Coexpression | VEGF_A_UP.V1_DN | 4.93e-06 | 193 | 216 | 10 | M2675 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 NCOA3 CENPC CENPE ZNF804A EFR3A PTPN4 SACS UBR5 ARHGEF7 VPS13A DLG1 PUM3 ANKS1A CUL1 FLNB WRN USP24 LRPPRC ELL2 WDFY3 | 9.17e-06 | 856 | 216 | 21 | M4500 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 2.83e-05 | 145 | 216 | 8 | M1810 | |
| Coexpression | EGUCHI_CELL_CYCLE_RB1_TARGETS | 2.92e-05 | 22 | 216 | 4 | M4455 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | ZNF609 ZBTB16 DIS3L SPTBN1 PTPN22 TTC3 PCNX2 PTPN4 SACS UBR5 EIF3L VPS13A DLG1 FBXO32 FLNB RASA2 POLA1 RALGPS2 ZNF507 CCNT1 LRPPRC PCID2 | 3.55e-05 | 1012 | 216 | 22 | M40864 |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP | 3.83e-05 | 196 | 216 | 9 | M4999 | |
| Coexpression | GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN | 4.31e-05 | 199 | 216 | 9 | M5771 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN | 4.48e-05 | 200 | 216 | 9 | M9653 | |
| Coexpression | GSE339_CD4POS_VS_CD8POS_DC_UP | 4.48e-05 | 200 | 216 | 9 | M5108 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP | 4.48e-05 | 200 | 216 | 9 | M5192 | |
| Coexpression | DAUER_STAT3_TARGETS_UP | 4.66e-05 | 48 | 216 | 5 | M12391 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | DOCK4 TPP2 CENPC PRDM2 NDUFV2 KLHL9 MME USP36 RASA2 ZNF507 SMC4 CENPU CCNT1 THBS1 ELL2 FBXO21 CWF19L1 | 5.34e-05 | 680 | 216 | 17 | M41089 |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 6.34e-05 | 120 | 216 | 7 | M42505 | |
| Coexpression | GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 6.68e-05 | 121 | 216 | 7 | M9157 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 6.79e-05 | 164 | 216 | 8 | M41676 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ZNF609 SPTBN1 NAPA PTPN22 TUBGCP4 TLR6 TTC3 TRIP11 PRDM2 EFR3A SACS UBR5 ARHGEF7 ETNK1 TRDMT1 SEL1L FLNB CENPU LRPPRC P3H2 CNDP2 PDCD10 SOD2 ATP5F1C | 7.04e-05 | 1215 | 216 | 24 | M41122 |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | SART3 NAPG PLXNB2 ITGB3 EFR3A PARP1 KLHL9 PTPRD MME STX7 NEBL FBXO21 ENPEP | 7.50e-05 | 437 | 216 | 13 | M4665 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN | DIS3L PEG3 NAPG ZNF804A MET PARP1 PKP1 ETNK1 FGF8 ANKRD13A WDFY3 FBXO21 CAPRIN1 | 7.67e-05 | 438 | 216 | 13 | M227 |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP | 9.02e-05 | 88 | 216 | 6 | M19287 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | TPP2 DIS3L PEG3 NAPG ZNF804A MET PARP1 PTPRD SACS PKP1 ETNK1 FGF8 PREX1 ANKS1A ECT2 ANKRD13A HECTD2 SMARCA4 WDFY3 FBXO21 CAPRIN1 | 9.95e-05 | 1009 | 216 | 21 | M157 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | SAMD9 CENPE TTC3 DLG1 PUM3 MME FBXO32 PLEC SEL1L RALGPS2 SMC4 CENPU SMC2 ECT2 NEMF CAPRIN1 MCOLN3 | 1.09e-04 | 721 | 216 | 17 | M10237 |
| Coexpression | MARKS_ACETYLATED_NON_HISTONE_PROTEINS | 1.15e-04 | 12 | 216 | 3 | M1160 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.16e-04 | 177 | 216 | 8 | M39245 | |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP | 1.23e-04 | 93 | 216 | 6 | MM1137 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.30e-04 | 180 | 216 | 8 | M8239 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | SART3 CENPE PEG3 CCDC18 WDR76 SLC29A2 ITGB3 ANKS1A POLA1 SMC4 CENPU SMC2 ECT2 PABPC3 TTLL4 | 1.40e-04 | 597 | 216 | 15 | MM1309 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NCOA3 CENPE ZNF804A UBR5 ARHGEF7 VPS13A PUM3 ANKS1A CUL1 FLNB WRN USP24 LRPPRC | 1.42e-04 | 466 | 216 | 13 | M13522 |
| Coexpression | GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP | 1.63e-04 | 186 | 216 | 8 | M8914 | |
| Coexpression | WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP | 1.67e-04 | 140 | 216 | 7 | M2435 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 2.02e-04 | 192 | 216 | 8 | M42501 | |
| Coexpression | PRC2_EZH2_UP.V1_DN | 2.02e-04 | 192 | 216 | 8 | M2737 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | PUM3 PTCD3 FLNB POLA1 SMC4 SMC2 ECT2 THBS1 ELL2 CSNK2A2 CD151 LY75 PCID2 SOD2 | 2.04e-04 | 550 | 216 | 14 | M16189 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | SART3 TPP2 CENPC CENPE STAT5A NDUFV2 PARP1 FGF8 PUM3 POLA1 WRN SMC4 SMC2 LSM6 SMARCA4 PDCD10 XRCC6 | 2.06e-04 | 761 | 216 | 17 | M11961 |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15 | 2.15e-04 | 36 | 216 | 4 | MM1284 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15 | 2.15e-04 | 36 | 216 | 4 | M2687 | |
| Coexpression | GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN | 2.17e-04 | 194 | 216 | 8 | M4687 | |
| Coexpression | YAGI_AML_FAB_MARKERS | 2.17e-04 | 194 | 216 | 8 | M5103 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | CENPC CENPE PTPN22 STAT5A UBR5 ARHGEF7 VPS13A POLA1 WRN SMC4 SMC2 SMARCA4 | 2.34e-04 | 426 | 216 | 12 | M9516 |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D7 | 2.39e-04 | 37 | 216 | 4 | M16093 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN | 2.41e-04 | 197 | 216 | 8 | M9916 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN | 2.49e-04 | 198 | 216 | 8 | M3792 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 2.49e-04 | 198 | 216 | 8 | M3195 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN | 2.58e-04 | 199 | 216 | 8 | M4635 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN | 2.58e-04 | 199 | 216 | 8 | M5151 | |
| Coexpression | GSE3982_MAST_CELL_VS_NKCELL_UP | 2.58e-04 | 199 | 216 | 8 | M5450 | |
| Coexpression | GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP | 2.58e-04 | 199 | 216 | 8 | M9238 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.58e-04 | 199 | 216 | 8 | M9180 | |
| Coexpression | GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN | 2.66e-04 | 200 | 216 | 8 | M4538 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN | 2.66e-04 | 200 | 216 | 8 | M8208 | |
| Coexpression | GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP | 2.66e-04 | 200 | 216 | 8 | M9608 | |
| Coexpression | GSE27786_LIN_NEG_VS_NEUTROPHIL_DN | 2.66e-04 | 200 | 216 | 8 | M4795 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_DN | 2.66e-04 | 200 | 216 | 8 | M3864 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP | 2.66e-04 | 200 | 216 | 8 | M6067 | |
| Coexpression | GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN | 2.66e-04 | 200 | 216 | 8 | M5059 | |
| Coexpression | GSE17721_LPS_VS_CPG_12H_BMDC_DN | 2.66e-04 | 200 | 216 | 8 | M4006 | |
| Coexpression | GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP | 2.66e-04 | 200 | 216 | 8 | M9080 | |
| Coexpression | GSE3982_DC_VS_TH1_UP | 2.66e-04 | 200 | 216 | 8 | M5481 | |
| Coexpression | GSE22886_NEUTROPHIL_VS_DC_DN | 2.66e-04 | 200 | 216 | 8 | M4465 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 2.66e-04 | 200 | 216 | 8 | M3188 | |
| Coexpression | GSE7852_THYMUS_VS_FAT_TREG_UP | 2.66e-04 | 200 | 216 | 8 | M5743 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | PUM3 PTCD3 FLNB POLA1 SMC4 SMC2 ECT2 THBS1 ELL2 CSNK2A2 CD151 LY75 PCID2 SOD2 | 2.99e-04 | 571 | 216 | 14 | MM1100 |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 3.11e-04 | 155 | 216 | 7 | M39041 | |
| Coexpression | BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES | 3.16e-04 | 259 | 216 | 9 | M40029 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | DOCK4 TPP2 RIDA SPTBN1 ZNF267 TTC3 EFR3A MET SACS UBR5 PUM3 POLA1 SLC35A1 CENPU CELSR1 SMARCA4 SOD2 | 3.17e-04 | 790 | 216 | 17 | M12490 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | SART3 CENPE PEG3 CCDC18 WDR76 SLC29A2 ITGB3 ANKS1A POLA1 SMC4 CENPU SMC2 ECT2 TTLL4 | 3.38e-04 | 578 | 216 | 14 | M2368 |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP | GDF5 CCDC168 MYO3B SELE NEBL CCDC150 ECT2 OPHN1 THBS1 SLC28A2 MCOLN3 | 3.69e-04 | 384 | 216 | 11 | M798 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CENPC CENPE TRIP11 SACS PUM3 STX7 WRN SMC4 CENPU SMC2 ECT2 CROT NEMF LUM PDCD10 | 3.82e-04 | 656 | 216 | 15 | M18979 |
| Coexpression | GSE6269_FLU_VS_E_COLI_INF_PBMC_DN | 4.06e-04 | 162 | 216 | 7 | M5654 | |
| Coexpression | CROMER_METASTASIS_DN | 4.43e-04 | 77 | 216 | 5 | M8417 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | TTC21A GAS8 RIBC1 STX7 PZP DNAH6 RPGRIP1L USP24 CFAP210 DCP1B DNAI2 DNAH11 | 4.58e-04 | 459 | 216 | 12 | M39136 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | DOCK4 NBEAL1 SPTBN1 PEG3 RIBC1 HMGCS2 NHLRC2 TUBGCP4 NEB PCNX2 NDEL1 SACS ARHGEF7 CIBAR1 PLEC PDPR AKIRIN1 SMC4 CFAP210 TEX15 SMC2 ECT2 THBS1 ELL2 MEIOC WDFY3 | 9.80e-08 | 778 | 215 | 26 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | DOCK4 NCOA3 NBEAL1 SPTBN1 PEG3 CCDC18 HEMGN HMGCS2 NHLRC2 TUBGCP4 NDEL1 SACS CIBAR1 VPS13A ETNK1 PDPR SMC4 TEX15 SMC2 ECT2 ELL2 MEIOC HECTD2 PDCD10 | 1.25e-06 | 776 | 215 | 24 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | DOCK4 PEG3 CCDC18 HEMGN HMGCS2 NDEL1 SACS CIBAR1 ETNK1 SMC4 TEX15 SMC2 ECT2 ELL2 MEIOC | 8.79e-06 | 382 | 215 | 15 | gudmap_developingGonad_e14.5_ ovary_500 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | CENPE NBEAL1 SPTBN1 PEG3 HMGCS2 NHLRC2 NEB WDR76 SLITRK1 PCNX2 NDEL1 ARHGEF7 CIBAR1 PLEC PDPR SMC4 TEX15 SMC2 ECT2 THBS1 ELL2 WDFY3 | 1.25e-05 | 770 | 215 | 22 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_200 | 1.39e-05 | 52 | 215 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | DOCK4 SPTBN1 PEG3 HEMGN HMGCS2 PCNX2 NDEL1 SACS ARHGEF7 CIBAR1 ETNK1 PLEC PDPR SMC4 CFAP210 TEX15 SMC2 ELL2 MEIOC NAPB SMARCA4 WDFY3 | 2.03e-05 | 795 | 215 | 22 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.41e-05 | 151 | 215 | 9 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | STAT5A STAT5B EFR3A CACNA2D1 WRN SMC4 LAMA4 SMC2 THBS1 LIPA CAPRIN1 | 2.50e-05 | 231 | 215 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | DOCK4 CENPE SPTBN1 PEG3 HEMGN HMGCS2 NHLRC2 TUBGCP4 SLITRK1 NDEL1 CIBAR1 SMC4 SMC2 ECT2 | 7.82e-05 | 409 | 215 | 14 | gudmap_developingGonad_e12.5_ovary_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | DOCK4 NCOA3 NBEAL1 SPTBN1 HEMGN NHLRC2 TUBGCP4 NDEL1 CIBAR1 SMC2 | 1.04e-04 | 225 | 215 | 10 | gudmap_developingGonad_e14.5_ ovary_1000_k3 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | DOCK4 CENPE NBEAL1 HMGCS2 NHLRC2 TUBGCP4 SLITRK1 CIBAR1 ECT2 ELL2 | 1.38e-04 | 233 | 215 | 10 | gudmap_developingGonad_e12.5_ovary_k5_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | DOCK4 SPTBN1 PEG3 HMGCS2 NEB NDEL1 ARHGEF7 CIBAR1 PDPR SMC4 TEX15 THBS1 MEIOC | 1.70e-04 | 387 | 215 | 13 | gudmap_developingGonad_e18.5_ovary_500 |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | DOCK4 SPTBN1 PTPRD PZP TRHDE COL6A3 RALGPS2 LAMA4 THBS1 ROBO1 LUM | 4.25e-09 | 200 | 216 | 11 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 5.36e-08 | 200 | 216 | 10 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 5.36e-08 | 200 | 216 | 10 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.14e-07 | 164 | 216 | 9 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | BTBD8 CENPE CCDC18 CIBAR1 TRDMT1 CENPU STEAP4 SH3PXD2B HECTD2 | 1.89e-07 | 174 | 216 | 9 | 1779e67382cb2644534ffb5b9b8f28d32935f4ea |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-07 | 184 | 216 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-07 | 184 | 216 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-07 | 184 | 216 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.80e-07 | 189 | 216 | 9 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.80e-07 | 189 | 216 | 9 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | CACNA2D2 TRPC5 TTC3 ZNF804A PCNX2 CNTNAP5 PTCHD4 NAPB GALNT9 | 4.15e-07 | 191 | 216 | 9 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | CACNA2D2 TRPC5 TTC3 ZNF804A PCNX2 CNTNAP5 PTCHD4 NAPB GALNT9 | 4.15e-07 | 191 | 216 | 9 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.34e-07 | 192 | 216 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-07 | 194 | 216 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-07 | 194 | 216 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.73e-07 | 194 | 216 | 9 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.73e-07 | 194 | 216 | 9 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.94e-07 | 195 | 216 | 9 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 4.94e-07 | 195 | 216 | 9 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 5.16e-07 | 196 | 216 | 9 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.16e-07 | 196 | 216 | 9 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.10e-07 | 200 | 216 | 9 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 6.10e-07 | 200 | 216 | 9 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-07 | 200 | 216 | 9 | dd5b753bb1333fa502b9d3a6d65a53a9882b2451 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.10e-07 | 200 | 216 | 9 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.42e-06 | 164 | 216 | 8 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.95e-06 | 171 | 216 | 8 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.95e-06 | 171 | 216 | 8 | 621f9da0bfa09c86fc89fd26919403e94cd56d2b | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-06 | 181 | 216 | 8 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.10e-06 | 182 | 216 | 8 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-06 | 182 | 216 | 8 | c84f44391932080df31c8765e363c3dff64b2bd1 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 3.50e-06 | 185 | 216 | 8 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.78e-06 | 187 | 216 | 8 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 4.09e-06 | 189 | 216 | 8 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-06 | 189 | 216 | 8 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-06 | 190 | 216 | 8 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-06 | 190 | 216 | 8 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.26e-06 | 190 | 216 | 8 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.42e-06 | 191 | 216 | 8 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.42e-06 | 191 | 216 | 8 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.60e-06 | 192 | 216 | 8 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.60e-06 | 192 | 216 | 8 | ff4b728a55c2550c806c47e9ae3d057c35df8464 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-alveolar_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.60e-06 | 192 | 216 | 8 | 2d3790bd80a7f214b37094121a2a86ff16362569 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.60e-06 | 192 | 216 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.78e-06 | 193 | 216 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.96e-06 | 194 | 216 | 8 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.96e-06 | 194 | 216 | 8 | eb23b171e429165dd26a64377eae7fa2ce25f547 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 5.15e-06 | 195 | 216 | 8 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.15e-06 | 195 | 216 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.15e-06 | 195 | 216 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.15e-06 | 195 | 216 | 8 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-06 | 195 | 216 | 8 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.35e-06 | 196 | 216 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.35e-06 | 196 | 216 | 8 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 5.35e-06 | 196 | 216 | 8 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.35e-06 | 196 | 216 | 8 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.35e-06 | 196 | 216 | 8 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.35e-06 | 196 | 216 | 8 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 5.35e-06 | 196 | 216 | 8 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 5.55e-06 | 197 | 216 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 5.55e-06 | 197 | 216 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 5.76e-06 | 198 | 216 | 8 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 5.76e-06 | 198 | 216 | 8 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.76e-06 | 198 | 216 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.76e-06 | 198 | 216 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 5.76e-06 | 198 | 216 | 8 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.98e-06 | 199 | 216 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.98e-06 | 199 | 216 | 8 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.98e-06 | 199 | 216 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Sepsis-URO|Sepsis / Disease, condition lineage and cell class | 5.98e-06 | 199 | 216 | 8 | 8e6dac82d1d0e759cd567f9c95b70cb4801d7caf | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.98e-06 | 199 | 216 | 8 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.21e-06 | 200 | 216 | 8 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.21e-06 | 200 | 216 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.21e-06 | 200 | 216 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.21e-06 | 200 | 216 | 8 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 6.21e-06 | 200 | 216 | 8 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.21e-06 | 200 | 216 | 8 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.21e-06 | 200 | 216 | 8 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.16e-06 | 151 | 216 | 7 | 7758cfbe8dca849c90bd6e8bc63310e53beeb8fd | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.16e-06 | 151 | 216 | 7 | b4a0546c1573b4b2290890307f2a5daf3a7cbb37 | |
| ToppCell | droplet-Liver-nan-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-06 | 152 | 216 | 7 | faa92f7c5a6db9f1eb7d8ec930ba7c8ed9fd1bf1 | |
| ToppCell | droplet-Liver-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-06 | 152 | 216 | 7 | 1febeeb7376e34b9f86c81b2cb1314ee12408864 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 157 | 216 | 7 | b72c6a1ed17bfc32d9dec193d934ea82e80b6bd5 | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.51e-05 | 163 | 216 | 7 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-05 | 163 | 216 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-05 | 166 | 216 | 7 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-05 | 166 | 216 | 7 | 9e98e6070055bfc780becee52d77830e06b6d854 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.83e-05 | 168 | 216 | 7 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-05 | 169 | 216 | 7 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.98e-05 | 170 | 216 | 7 | 3174ea9cf93892a8b41de10fd4ff6f06bb41502d | |
| ToppCell | Immune_cells-pro-B|Immune_cells / Lineage and Cell class | 2.13e-05 | 172 | 216 | 7 | 096636f2589fa56d15942aac96641c16fd5fa78d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 2.21e-05 | 173 | 216 | 7 | 8a9dd85f718564c07cf3120ad648daeb60c94fc5 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-05 | 174 | 216 | 7 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.47e-05 | 176 | 216 | 7 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-05 | 176 | 216 | 7 | cd4b9211652596c42e7af318bcd464681daebb10 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 177 | 216 | 7 | c6812679aa6522d03bd29144e71c5fae6a92325e | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 177 | 216 | 7 | ff97398d2adb83063b7c53a264bfae86ea7ea304 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-05 | 177 | 216 | 7 | 3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-05 | 177 | 216 | 7 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-05 | 178 | 216 | 7 | da1695a936dbe3ca9ee3fb28ceb60511c47b35f8 | |
| Disease | Malignant neoplasm of prostate | NCOA3 ZBTB16 SAMD9 TLR6 ITGB3 MET PARP1 PIK3R2 MME STAB2 ARHGEF5 STEAP4 PPL ROBO1 EPCAM SOD2 | 8.66e-06 | 616 | 208 | 16 | C0376358 |
| Disease | Prostatic Neoplasms | NCOA3 ZBTB16 SAMD9 TLR6 ITGB3 MET PARP1 PIK3R2 MME STAB2 ARHGEF5 STEAP4 PPL ROBO1 EPCAM SOD2 | 8.66e-06 | 616 | 208 | 16 | C0033578 |
| Disease | colon adenocarcinoma (is_implicated_in) | 3.18e-05 | 26 | 208 | 4 | DOID:234 (is_implicated_in) | |
| Disease | polydactyly (implicated_via_orthology) | 4.95e-05 | 2 | 208 | 2 | DOID:1148 (implicated_via_orthology) | |
| Disease | Niemann-Pick Disease, Type C1 | 4.95e-05 | 2 | 208 | 2 | C3179455 | |
| Disease | Niemann-Pick Disease, Type C | 4.95e-05 | 2 | 208 | 2 | C0220756 | |
| Disease | Niemann-Pick Disease, Type D | 4.95e-05 | 2 | 208 | 2 | C0268247 | |
| Disease | coronary artery disease (is_implicated_in) | 7.84e-05 | 100 | 208 | 6 | DOID:3393 (is_implicated_in) | |
| Disease | Spinocerebellar Ataxia Type 2 | 9.43e-05 | 34 | 208 | 4 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 9.43e-05 | 34 | 208 | 4 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 9.43e-05 | 34 | 208 | 4 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 9.43e-05 | 34 | 208 | 4 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 9.43e-05 | 34 | 208 | 4 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 9.43e-05 | 34 | 208 | 4 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 1.06e-04 | 35 | 208 | 4 | C0752122 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.19e-04 | 14 | 208 | 3 | EFO_0004611, EFO_0008589 | |
| Disease | Nasal Type Extranodal NK/T-Cell Lymphoma | 1.48e-04 | 3 | 208 | 2 | C0392788 | |
| Disease | Lymphoma, Extranodal NK-T-Cell | 1.48e-04 | 3 | 208 | 2 | C1955906 | |
| Disease | response to anti-tuberculosis drug, drug-induced liver injury | 1.48e-04 | 3 | 208 | 2 | EFO_0004228, EFO_0007918 | |
| Disease | Hypercholesterolemia | 1.63e-04 | 39 | 208 | 4 | C0020443 | |
| Disease | Disproportionate short stature | 2.17e-04 | 77 | 208 | 5 | C0878659 | |
| Disease | neuroimaging measurement | ZBTB16 SAMD9 NBEAL1 SPTBN1 PLXNB2 PTPN4 NDEL1 PLEC ANKS1A PDPR RALGPS2 STPG2 THBS1 CELSR1 SH3PXD2A PABPC3 ROBO1 ANKFN1 DNAH11 | 2.19e-04 | 1069 | 208 | 19 | EFO_0004346 |
| Disease | Liver carcinoma | CENPE WDR76 MET PKP1 PZP STAB2 APOF CENPU ECT2 ROBO1 HERC5 SOD2 | 2.77e-04 | 507 | 208 | 12 | C2239176 |
| Disease | Gilles de la Tourette syndrome (implicated_via_orthology) | 2.94e-04 | 4 | 208 | 2 | DOID:11119 (implicated_via_orthology) | |
| Disease | Cardiomyopathies | 3.30e-04 | 130 | 208 | 6 | C0878544 | |
| Disease | Primary Ciliary Dyskinesia | 3.37e-04 | 47 | 208 | 4 | C4551720 | |
| Disease | carotid artery disease (is_implicated_in) | 4.82e-04 | 22 | 208 | 3 | DOID:3407 (is_implicated_in) | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5.36e-04 | 53 | 208 | 4 | C1961099 | |
| Disease | breast cancer (implicated_via_orthology) | 7.08e-04 | 25 | 208 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | nephronophthisis (is_implicated_in) | 7.28e-04 | 6 | 208 | 2 | DOID:12712 (is_implicated_in) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.54e-04 | 152 | 208 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 7.96e-04 | 26 | 208 | 3 | OBA_2045191 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 1.01e-03 | 7 | 208 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | factor VIII measurement, coronary artery disease | 1.26e-03 | 113 | 208 | 5 | EFO_0001645, EFO_0004630 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 1.35e-03 | 8 | 208 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | Myopathies, Nemaline | 1.35e-03 | 8 | 208 | 2 | C0206157 | |
| Disease | beta-Ala-His dipeptidase measurement | 1.35e-03 | 8 | 208 | 2 | EFO_0008033 | |
| Disease | severe acute respiratory syndrome, COVID-19 | CATSPERD PTPN4 PTPRD ARHGEF7 MYO3B EIF3L COL6A3 CACNA2D1 WRN HELQ | 1.35e-03 | 447 | 208 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | Adenocarcinoma | 1.41e-03 | 116 | 208 | 5 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 1.41e-03 | 116 | 208 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.41e-03 | 116 | 208 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.41e-03 | 116 | 208 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.41e-03 | 116 | 208 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.41e-03 | 116 | 208 | 5 | C0205641 | |
| Disease | Cardiomyopathies, Primary | 1.45e-03 | 69 | 208 | 4 | C0033141 | |
| Disease | breast size | 1.45e-03 | 69 | 208 | 4 | EFO_0004884 | |
| Disease | Myocardial Diseases, Secondary | 1.45e-03 | 69 | 208 | 4 | C0036529 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.52e-03 | 118 | 208 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | feeling tense measurement | 1.61e-03 | 33 | 208 | 3 | EFO_0009596 | |
| Disease | Malignant neoplasm of breast | NCOA3 TTC3 STAT5A PARP1 PTPRD MME FLNB ECT2 HELQ ZNF365 EPG5 THBS1 RPRD1A P3H2 ROBO1 ENPEP SOD2 | 1.67e-03 | 1074 | 208 | 17 | C0006142 |
| Disease | response to clopidogrel, response to acetylsalicylate, major adverse cardiovascular event measurement | 1.72e-03 | 9 | 208 | 2 | EFO_0020863, GO_1903492, GO_1903493 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.72e-03 | 9 | 208 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Nephronophthisis | 1.72e-03 | 9 | 208 | 2 | cv:C0687120 | |
| Disease | telomere length | 1.79e-03 | 313 | 208 | 8 | EFO_0004505 | |
| Disease | Squamous cell carcinoma | 1.90e-03 | 124 | 208 | 5 | C0007137 | |
| Disease | aspartate aminotransferase measurement | BTBD8 CACNA2D2 NHLRC2 PTPRD SEPTIN14 PUM3 TRDMT1 FLNB TMEM106B LIPA CROT NPHP3 ROBO1 MYO15A LY75 | 1.98e-03 | 904 | 208 | 15 | EFO_0004736 |
| Disease | Parkinson's disease (is_implicated_in) | 2.07e-03 | 76 | 208 | 4 | DOID:14330 (is_implicated_in) | |
| Disease | Necrotizing encephalopathy, infantile subacute, of Leigh | 2.08e-03 | 36 | 208 | 3 | C2931891 | |
| Disease | Primary ciliary dyskinesia | 2.08e-03 | 36 | 208 | 3 | cv:C0008780 | |
| Disease | Eczema, Infantile | 2.08e-03 | 36 | 208 | 3 | C0086196 | |
| Disease | Leigh Syndrome due to Mitochondrial Complex V Deficiency | 2.08e-03 | 36 | 208 | 3 | C1850600 | |
| Disease | Dermatitis, Atopic | 2.08e-03 | 36 | 208 | 3 | C0011615 | |
| Disease | Leigh Syndrome due to Mitochondrial Complex III Deficiency | 2.08e-03 | 36 | 208 | 3 | C1850598 | |
| Disease | Leigh Syndrome Due To Mitochondrial Complex II Deficiency | 2.08e-03 | 36 | 208 | 3 | C1850597 | |
| Disease | Leigh Syndrome due to Mitochondrial Complex IV Deficiency | 2.08e-03 | 36 | 208 | 3 | C1850599 | |
| Disease | dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement | 2.14e-03 | 10 | 208 | 2 | EFO_0801544 | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 2.14e-03 | 10 | 208 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | Meckel-Gruber syndrome | 2.14e-03 | 10 | 208 | 2 | cv:C0265215 | |
| Disease | Ischemic stroke | 2.21e-03 | 324 | 208 | 8 | HP_0002140 | |
| Disease | LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY | 2.25e-03 | 37 | 208 | 3 | C1838951 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 2.61e-03 | 11 | 208 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | PR interval | DOCK4 MYH11 SPTBN1 NHLRC2 DLG1 PPIL2 PLEC THBS1 SH3PXD2A DNAH11 | 2.84e-03 | 495 | 208 | 10 | EFO_0004462 |
| Disease | nicotine dependence (implicated_via_orthology) | 3.12e-03 | 12 | 208 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | sialic acid-binding Ig-like lectin 14 measurement | 3.12e-03 | 12 | 208 | 2 | EFO_0008284 | |
| Disease | cortical surface area measurement | GDF5 ZBTB16 SAMD9 REPS1 NBEAL1 SPTBN1 PLXNB2 NDEL1 ANKS1A FLNB CACNA2D1 RALGPS2 STPG2 THBS1 CELSR1 ROBO1 ANKFN1 XRCC6 DNAH11 | 3.24e-03 | 1345 | 208 | 19 | EFO_0010736 |
| Disease | Fatty Liver | 3.53e-03 | 88 | 208 | 4 | C0015695 | |
| Disease | Steatohepatitis | 3.53e-03 | 88 | 208 | 4 | C2711227 | |
| Disease | myocardial infarction | 3.54e-03 | 350 | 208 | 8 | EFO_0000612 | |
| Disease | adipose tissue measurement | 3.94e-03 | 45 | 208 | 3 | EFO_0004764 | |
| Disease | forced expiratory volume | GDF5 ZBTB16 PLXNB2 TRIP11 PREX1 ANKS1A RALGPS2 ANO10 ZNF365 ANKRD13A SH3PXD2A ANKFN1 HERC5 | 4.14e-03 | 789 | 208 | 13 | EFO_0004314 |
| Disease | serum IgG glycosylation measurement | ZNF804A ITGB3 CNTNAP5 STAB2 WRN TMEM106B ELL2 CSNK2A2 ANKFN1 ENPEP | 4.18e-03 | 523 | 208 | 10 | EFO_0005193 |
| Disease | multiple myeloma, monoclonal gammopathy | 4.26e-03 | 14 | 208 | 2 | EFO_0000203, EFO_0001378 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 4.26e-03 | 14 | 208 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Leigh Disease | 4.46e-03 | 47 | 208 | 3 | C0023264 | |
| Disease | mean fractional anisotropy measurement | 4.63e-03 | 95 | 208 | 4 | EFO_0008399 | |
| Disease | cerebral amyloid deposition measurement | 4.63e-03 | 95 | 208 | 4 | EFO_0007707 | |
| Disease | pulse pressure measurement | MYH11 NBEAL1 PLXNB2 STAT5B MET PTPRD FBXO32 PTCD3 NPC1 USP36 FLNB COL6A3 PDPR NEBL RALGPS2 PCDHA10 GALNT9 ENPEP XRCC6 | 4.68e-03 | 1392 | 208 | 19 | EFO_0005763 |
| Disease | coronary artery disease | MYH11 REPS1 NBEAL1 HEMGN AS3MT PARP1 PREX1 ANKS1A NPC1 COL6A3 APOB OPHN1 EPG5 TMEM106B LIPA SMARCA4 FBXO21 | 4.89e-03 | 1194 | 208 | 17 | EFO_0001645 |
| Disease | autoimmune thrombocytopenic purpura (is_implicated_in) | 4.89e-03 | 15 | 208 | 2 | DOID:8924 (is_implicated_in) | |
| Disease | infant head circumference | 4.89e-03 | 15 | 208 | 2 | EFO_0004577 | |
| Disease | osteoarthritis (implicated_via_orthology) | 4.89e-03 | 15 | 208 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | REPS1 NHLRC2 FGB ZNF574 NPC1 APOB LIPA RASSF6 MTTP SMARCA4 CWF19L1 DNAH11 | 4.91e-03 | 713 | 208 | 12 | EFO_0005689 |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 5.01e-03 | 49 | 208 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | Non-Small Cell Lung Carcinoma | 5.07e-03 | 156 | 208 | 5 | C0007131 | |
| Disease | prostate cancer (is_marker_for) | 5.07e-03 | 156 | 208 | 5 | DOID:10283 (is_marker_for) | |
| Disease | mean corpuscular hemoglobin concentration | ZBTB16 SAMD9 SIGLEC5 NEB UBR5 VPS13A STX7 PREX1 RAD52 CUL1 NPHP3 ELL2 RPRD1A GALNT9 MYO15A LY75 | 5.35e-03 | 1105 | 208 | 16 | EFO_0004528 |
| Disease | Ataxia, Motor | 5.56e-03 | 16 | 208 | 2 | C0278161 | |
| Disease | Schizoaffective disorder-bipolar type | 5.56e-03 | 16 | 208 | 2 | EFO_0009965 | |
| Disease | Tremor, Rubral | 5.56e-03 | 16 | 208 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 5.56e-03 | 16 | 208 | 2 | C0750937 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QAIVQKYKYLAEDSN | 546 | Q13523 | |
| MENYNIFNEYILKQV | 771 | Q9UKU6 | |
| YEQILNTKLAEQYES | 156 | Q9H9L7 | |
| FQNLIDYIYEEQIKT | 301 | Q7L0X2 | |
| QKTQNDVDIADVAYY | 201 | P16422 | |
| KQYVEYQDQILQATQ | 2531 | Q9HCE0 | |
| SQNDSIYEDQQDKYT | 416 | O00472 | |
| QVYNYAKDNNIKQDS | 146 | Q8TC20 | |
| VVDQKVYIYDYENNS | 111 | Q86XM0 | |
| AQETVADYQQTIKKY | 506 | Q14203 | |
| NFKNKVNYSYAAVQI | 196 | Q9NY47 | |
| SGVQQLIQYYQDQKD | 251 | Q13790 | |
| LIQYYQDQKDANISQ | 256 | Q13790 | |
| LYQEYSDVVLNKEIQ | 1096 | Q12774 | |
| YNQVKQIIEEQSGSY | 881 | Q12959 | |
| LKQLYQDYSDVQAQE | 361 | Q71F23 | |
| QFKEQIDIYEALYVQ | 1081 | Q96DT5 | |
| AINKSYYNVVLQNIL | 266 | Q14155 | |
| YYNVVLQNILETENE | 271 | Q14155 | |
| QAFEVAYQLALQAQK | 1056 | Q92625 | |
| NYRIIGYVKNISQEN | 76 | Q14002 | |
| QLENMEANVKSQYAY | 406 | O60563 | |
| EANVKSQYAYAAQNL | 411 | O60563 | |
| DYKQEQQYVLAVTAS | 751 | Q9NYQ6 | |
| TGRYAYQSQIKVEQN | 491 | Q05D60 | |
| IKQNNAIDIYEEYFN | 121 | Q9GZS0 | |
| EPETLKQQNQYQASY | 531 | Q14444 | |
| EDNVQKNYELLYTSL | 541 | Q14156 | |
| QSFVYIYDNGQQKVS | 681 | Q6ZS30 | |
| EENKYVNQNYVTNTN | 886 | Q09MP3 | |
| YVLNYLNETQQLTQE | 991 | P20742 | |
| YAYEAVEQLNIKAKN | 126 | Q13356 | |
| GDNVENNKENLRYYV | 446 | Q15283 | |
| QLNSLLKTYNIFYEN | 56 | Q6ZTQ3 | |
| YTAEEYQAIQKALRQ | 31 | P43351 | |
| VAKELYQTESNYVNI | 456 | Q9H8V3 | |
| QVVKQLAYALNYLED | 626 | P52333 | |
| YVYQIQEVQESKKFN | 181 | O60890 | |
| SLVQTQEQYELVYNA | 271 | Q9Y2R2 | |
| VILKGNEDYINANYI | 696 | P29074 | |
| YIQYGNEEQRKQAFE | 186 | Q15397 | |
| YNEYIVYDIAQVNLK | 986 | P09874 | |
| QVYEDYNCTLNQTNI | 61 | Q9Y6F1 | |
| LVELYISNNYIAVNQ | 1001 | Q6ZRR7 | |
| LNKYEQETLENQNLY | 56 | Q9NW15 | |
| VNGYEAKVYTVNNVN | 261 | Q8IZ07 | |
| QTNTYDAQYERAIQE | 516 | Q8IZ07 | |
| VYETVQNIYSAKKEN | 611 | O94952 | |
| AYEQALNLYTELLNN | 271 | Q96EY7 | |
| SYEVQLFDENNQKIQ | 141 | P23467 | |
| YKINVQKSQAFLYNN | 731 | O00370 | |
| ILFIDSANNVVYKQY | 476 | P43026 | |
| NYASTVKIEFQLQAY | 126 | O15232 | |
| TQDLVQEKYLEYQQV | 246 | O15481 | |
| VNNVYDVDNKTYLIR | 26 | O60524 | |
| YNYSNVIYVDKENNK | 1201 | Q68CZ1 | |
| DVYDQLIFAVNQYLQ | 121 | Q8TDD5 | |
| NELASDVRYHQQYQK | 256 | Q86VF7 | |
| NYANENLQYLFNKIV | 1606 | Q9UKN7 | |
| KQDLAYERQYEQQTY | 31 | Q9Y262 | |
| DYYQAIKVLENIELN | 286 | Q9Y262 | |
| NIKYSTFEVQQYANA | 276 | Q9HCQ5 | |
| EKQALNQAVYDNDSY | 26 | Q8WXK4 | |
| ISVTNQNRKEYVQLY | 606 | Q5U5R9 | |
| QTYVLGANNQETVKY | 66 | Q69YN2 | |
| QYVDQTDLEKYNNVE | 66 | P54868 | |
| NQQYNVTYVVKERGD | 2566 | O75369 | |
| VQNEANKYQISVNKY | 361 | P02675 | |
| QTQYILEGYSILDNN | 1501 | A6NKB5 | |
| LLDTVNNVFKKYQYQ | 141 | Q9BUL8 | |
| QYTQKYYDEIINALE | 1796 | O15031 | |
| YSYQNEAVAIENIKR | 136 | P55157 | |
| NKLYYQLEQETGIQT | 106 | Q8NCN5 | |
| SQQYQQAVKDYELEA | 791 | O60437 | |
| NYKEDEYFENIIQNL | 501 | P08473 | |
| ANTYNLIEVDKYVNN | 161 | Q9P2J3 | |
| EALYQTKYQELQVSA | 301 | Q8N1N4 | |
| LQNASETVKYLNNLY | 1101 | O60449 | |
| QNKEEIEYLNSILSY | 51 | P16581 | |
| LNAKEQNIVFNAETY | 1056 | P42704 | |
| DNLQYYLQVDVLESQ | 526 | Q9UGJ1 | |
| NYTLEQYQKTSLAQE | 801 | Q07075 | |
| LYENITFVYNSEQLN | 446 | Q8IVL5 | |
| YQGVNLYVKNLDDSI | 291 | Q4VXU2 | |
| QYVAAYQQLTSEKEV | 621 | Q08379 | |
| QDNLTIDTQYYLAQQ | 1201 | P09884 | |
| QTSYAQEQYAKEQAR | 1016 | Q9GZU2 | |
| QQEKDSLVYQYLQKV | 31 | Q8NBF2 | |
| NIYQENFSEYQEIAV | 141 | Q9BXL5 | |
| EEIQYLSNLQYFAVT | 696 | Q6P9F7 | |
| YQVVNLYVKNLDDGI | 291 | Q9H361 | |
| YEVKMYENQVNQTLV | 246 | Q9Y5I2 | |
| VNQTNKRDYVSKYIN | 856 | Q9UII4 | |
| QTKTNVKELQYYVGQ | 136 | O15118 | |
| AVGAQLKVYHQQYQD | 441 | O00459 | |
| INQYLQQVYEAIDSR | 6 | Q5JVF3 | |
| QNDDNFLNIIYEAYL | 591 | Q8IZD4 | |
| VLENNYTALQNAKYE | 151 | P55075 | |
| KFTYLINYIQDEINT | 4321 | P04114 | |
| KYNIYNQVALVAINI | 136 | O60308 | |
| ENINKNDYYTISQRA | 226 | Q9C0G6 | |
| DQYQKKNYEQSLSIQ | 931 | Q8NCX0 | |
| RFEKAAYDNVYQQLQ | 186 | Q8NA47 | |
| TIFQAEAQYLQIYAV | 1371 | Q8N1I0 | |
| GKALEVYTAAYQNIQ | 196 | A1XBS5 | |
| VYTAAYQNIQNIDED | 201 | A1XBS5 | |
| KEQEQYIATQYKEAI | 1116 | Q5T9S5 | |
| ASGVNQLVDIYEKYQ | 51 | P54289 | |
| GNYYNIKNLRNEESV | 921 | Q03188 | |
| LLQYNTEDAYTVQQL | 611 | Q13616 | |
| NIIQEEYQEYRQTKG | 1016 | Q8TF46 | |
| QIIYSSNRNIKNYEE | 116 | Q5XKL5 | |
| YLNSYMNKQDVVNAV | 1081 | P12111 | |
| QSYLLYSRDQVQKEQ | 106 | A6NJJ6 | |
| DAEIQKDVQTYYGQV | 6 | Q9HBK9 | |
| NYSDLNYKITQQQKA | 421 | Q9NY37 | |
| LEQLFEMADQYQYQV | 131 | P09543 | |
| YINNTDFKQLYQILT | 116 | P19784 | |
| TVNENLENYYLEVNQ | 271 | P51884 | |
| EQTEEYVNGQLKNKY | 46 | P62312 | |
| VTENVVNLYQNYSEL | 336 | P05106 | |
| IDADVLQNYQEYNLA | 221 | P36542 | |
| LSNYYQNKENILESV | 3181 | Q8NDH2 | |
| IIYNEKQGDVQFIDY | 316 | Q9HBU6 | |
| TKVNVQVIYLYENDL | 76 | Q9NZU1 | |
| NNVEDLQKFLQAEYY | 501 | Q8TDG4 | |
| AYAYYQQLNTELKEN | 111 | P48509 | |
| YNKENLFNSLNYDVA | 46 | Q969P5 | |
| NAQGQQEIVYYVLSE | 471 | Q9BQA5 | |
| VIQNYNKALQQLEKY | 281 | Q15020 | |
| DENLEYTKTVLNYLQ | 581 | Q9NZJ4 | |
| TYKQMENDIQLYQSQ | 661 | Q02224 | |
| ENLYYNGVNIIDLAK | 331 | Q8WYK1 | |
| NISENLNYYIDGKIQ | 561 | Q13029 | |
| VNISYYVDEKIFQNE | 336 | Q9UKG9 | |
| YAYIQKLTQIETGEN | 1626 | P23468 | |
| VQKYLNSVQYIEELQ | 256 | Q86X27 | |
| NDNLVYVYNLGTKDV | 901 | Q16363 | |
| TNLITHYNLEQAYNK | 81 | A0JLT2 | |
| VQYLSSQDEKYQAIG | 251 | Q13835 | |
| ATNYIYVLNEEDLQK | 66 | P08581 | |
| NITNNNYYSVEVENI | 151 | Q9NUM4 | |
| NYYSVEVENITAQVQ | 156 | Q9NUM4 | |
| NYSAQKYGIIENVNK | 591 | A2RUB1 | |
| NLDAAVYQVTYQLKI | 111 | P78382 | |
| AAIDVNTVANEVYKY | 31 | O14717 | |
| ITDEQRQYYVNQFKT | 281 | Q96D71 | |
| YYLANKSSQAQAQEL | 221 | Q14542 | |
| YSNVGLQIQTYELQE | 86 | Q6ZU15 | |
| IQYYQFLAEKGDVQA | 361 | Q9UBV2 | |
| QLYKQALEISENAYG | 1006 | Q7Z494 | |
| EALATLYQKQNKYEQ | 1031 | Q7Z494 | |
| VLYYLQNNLETADQF | 1101 | Q7Z494 | |
| QQYTNQLAKETDKYI | 56 | O15400 | |
| FEEQDNVYLLQYSIQ | 801 | Q5K651 | |
| VEQYYQFLKVSNVSA | 551 | Q6ZW05 | |
| FVSENVTQYLQYKQE | 136 | Q9Y6Q9 | |
| VTQYLQYKQEDLVNT | 141 | Q9Y6Q9 | |
| QYKQEDLVNTSVYNI | 146 | Q9Y6Q9 | |
| QDINAQSLEKVQQYY | 1491 | Q8TCU6 | |
| AYLLQQTDEYVANLT | 551 | P51532 | |
| VKYSYQQNKLNLEVT | 126 | O15389 | |
| QQTQEYFIIQYQESL | 166 | P51692 | |
| EQQSQEEYLSDIAYK | 406 | Q14191 | |
| EQYQKAIDIYEQVGT | 176 | P54920 | |
| NEFVAYQQLSQYKNK | 491 | O43868 | |
| ATDYDNIEIQQQYSD | 6 | Q01082 | |
| QQTQEYFIIQYQESL | 166 | P42229 | |
| EQQDMDAVQILLYQY | 146 | Q8N957 | |
| IFYYKDNILVTNEDQ | 446 | Q8N957 | |
| KAIENAKQYQFYQTE | 136 | Q0VFZ6 | |
| SQNEKLNRYNYIEGT | 446 | Q96KP4 | |
| IENLTQQYEEKAAAY | 1401 | P35749 | |
| INDFNTVNEIYKQYF | 86 | P52758 | |
| QKQESSYYNIVKTQS | 2386 | A4UGR9 | |
| YNTNVVYNTEGKLVA | 161 | O95498 | |
| SVNFKNIYVLQELDN | 96 | P12956 | |
| YQSLIRYVENNKNAD | 36 | Q9Y3C8 | |
| ILNERDNCQYVYNVD | 806 | P07996 | |
| VNNYTKQEVAYIGIT | 2536 | Q96RL7 | |
| QQILEYAYTATLQAK | 81 | Q05516 | |
| EKQLEYYQSQQASGF | 286 | Q70YC5 | |
| LVDTQYKEYQERQQN | 2321 | Q8IZQ1 | |
| KAQQDYLNSVIYTNQ | 351 | Q8N443 | |
| LQNLEYLNVEYNAIQ | 446 | Q96PX8 | |
| EKAVQLYQQTANVFE | 131 | Q99747 | |
| VYENDVLEQLKQALY | 116 | Q96P16 | |
| YVVVSNYKKQENSEL | 171 | Q5TCZ1 | |
| QYVVVANYQKQESSE | 156 | A1X283 | |
| SYYENVNIKRDQQQN | 171 | Q8N412 | |
| KQQYIEQSQAEIYHN | 101 | Q9NPL8 | |
| YLTKQQQIDTGENLY | 366 | Q14586 | |
| LYQTLVQESQYQCLE | 66 | Q6ZN55 | |
| STNTAYRQQYEEQQK | 996 | O15014 | |
| IIQVDKAYDYLVQNT | 501 | P29144 | |
| VLQDQLQEVYENYEQ | 1501 | P53804 | |
| SIVAFYIYEQTKNAQ | 1231 | Q9NTJ3 | |
| YIYEQTKNAQFIIIS | 1236 | Q9NTJ3 | |
| NNLKINQYPESNAEY | 106 | Q687X5 | |
| YIIQYNLANAIEAAD | 1156 | Q8WWQ8 | |
| TVDQQSQYIQGYKIL | 696 | Q9Y6N7 | |
| YAAQLEQYQKAIEIY | 171 | Q9H115 | |
| EQYQKAIEIYEQVGA | 176 | Q9H115 | |
| AAYVNNLNVTEEKYQ | 56 | P04179 | |
| QYINAIKDYELQLVT | 1411 | Q15149 | |
| AIEYYEAAQKINGQD | 781 | Q8NDW8 | |
| YKQQLEAVNEAIKSY | 836 | O95347 | |
| YYIKENETESLQILN | 181 | Q9Y2C9 | |
| LEKAVFYSEYQNISN | 261 | Q96K49 | |
| DQNYNYEQVNKAIND | 811 | Q8TCN5 | |
| VNEYKENQNIAYVSL | 21 | Q9H967 | |
| TQDVVYLQQQLQAYA | 1081 | Q15643 | |
| EAIQLIINYSYINLN | 841 | Q9UPU5 | |
| LQDKSNRETELYQYN | 941 | Q6PGP7 | |
| ATVKQALQEAEIYYN | 46 | Q9UL62 | |
| ALQEAEIYYNVNINC | 51 | Q9UL62 | |
| NDSYVINSVIYELNV | 556 | Q8WU66 | |
| LYQYLQEKILQQTNV | 801 | Q5QJ38 | |
| LEYNYNQFSTLLKNV | 2201 | Q9BXT5 | |
| YSVNKKNAEYQANAD | 811 | Q14679 | |
| VKYSYQQNKLNLEVT | 126 | Q08ET2 | |
| NVKVVLNQQAYVLFY | 406 | Q9P275 | |
| QATKAQQYVDSYVQE | 481 | Q13507 | |
| AVKLTYQDAVNLQNY | 1816 | O95071 | |
| YQDAVNLQNYVEEKL | 1821 | O95071 | |
| VVDSVNNQQDFKYTL | 156 | Q7Z570 | |
| TDIKNYYNDITLNNL | 231 | O95995 | |
| QDQEQKIYAQIFREY | 236 | P23276 | |
| DEAEALYQTKYQELQ | 351 | Q7Z794 | |
| INFILNKTGQEQVYY | 156 | P38571 | |
| QLCINIANEQIQYYF | 736 | Q8WXR4 | |
| VQINDNYYEDLTAKD | 186 | P19404 | |
| QYAQSYKQVSVLEDD | 86 | Q9GZM8 | |
| NISNLQYKEQNYKAT | 651 | O76041 | |
| NVNQIQSDNVYKDEY | 1426 | P20929 |